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1. Zusammenfassung 
Die Elemente Eisen und Sauerstoff sind für die Erythropoiese von besonderer 
Bedeutung. Eisen ist der essentielle Bestandteil von Häm, welches in Erythroblasten 
gebildet wird, um Sauerstoff zu binden und über den Blutkreislauf im ganzen Körper zu 
verteilen. Außerdem beeinflusst die Verfügbarkeit von Sauerstoff die Expression des 
Hormons Erythropoietin, dessen Konzentration im Körper die Neubildung von 
Erythrozyten reguliert. In dieser Arbeit wird mit Hilfe eines primären erythroiden 
Zellsystems gezeigt, wie es differenzierenden Erythroblasten gelingt, Eisenimport und 
Speicherung sowie die Synthese von Protoporphyrin IX so zu regulieren, dass eine 
optimale Abstimmung zwischen den einzelnen Mechanismen gewährleistet wird. Das ist 
deshalb von Bedeutung, da ein Überschuss an Eisen als auch an Protoporphyrin IX 
aufgrund ihrer Toxizität eine normale Erythropoiese behindern würde. Wir konnten 
zeigen, dass die Hauptbestandteile des zellulären Eisenstoffwechsels nicht so exprimiert 
werden, wie es das zelluläre Eisen Regulationssystem erwarten lässt. Die Ursache 
hierfür liegt in der Kopplung des Eisenimports mit der sofortigen Verwertung in den 
Mitochondrien, die trotz der gesteigerten Eisenaufnahme dazu führt, dass im Zytosol 
praktisch kein freies Eisen vorhanden ist. Zusätzliche Daten, die mit iron regulatory 
protein (IRP) defizienten Erythroblasten gewonnen wurden, zeigen, dass die beiden 
IRPs unterschiedlich relevant für die Regulation des Eisenstoffwechsels sind, was 
wiederum eine der Situation angepasste Expression der beteiligten Proteine erlaubt. 
Weiters konnten wir feststellen, dass sich eine Verknappung der Sauerstoffversorgung 
auf die Aktivität der IRPs auswirkt. Überraschenderweise ist dieser Effekt an die unter 
diesen Bedingungen geringere Bereitschaft der Erythroblasten vollständig zu 
differenzieren gekoppelt und wird deshalb nur indirekt durch die geringere 
Sauerstoffkonzentration verursacht. Vielmehr konnten wir zeigen, dass eine niedrige 
Sauerstoffkonzentration die Proliferation unreifer Erythroblasten begünstigt, während 
eine Erhöhung der Konzentration die vollständige Differenzierung ermöglicht. Diese 
Beobachtung korreliert mit den in vivo Gegebenheiten in hämatopoietischen Geweben. 
Hier befinden sich unreife Vorläuferzellen in Regionen mit geringer 
Sauerstoffversorgung, während differenzierende Zellen sich mit zunehmendem 
Reifegrad in Richtung höherer Sauerstoffkonzentration orientieren. Veränderungen der 
Sauerstoffversorgung in hämatopoietischen Geweben bewirken daher eine direkte 
Regulierung der Erythropoiese, zusätzlich zur indirekten Regulation über Erythropoietin. 
Ferner führt die Zugabe des HIF-Aktivators Dimethyloxalylglycin bei kultivierten 
Erythroblasten zu den gleichen Ergebnissen wie eine Inkubation bei niedriger 
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Sauerstoffversorgung. Daraus schließen wir, dass die Aktivierung von HIFs für die 
direkte, sauerstoffabhängige Regulierung der Erythropoiese verantwortlich ist.  
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2. Abstract 
The chemical elements iron and oxygen are of special importance for the generation of 
red blood cells. Iron is essential for the formation of heme that is synthesized in 
erythroblasts in order to bind oxygen in the lungs and to distribute it all over the body via 
the blood circulation. Furthermore, oxygen influences the expression of the glycoprotein 
hormone erythropoietin, whose concentration regulates the production of erythrocytes. 
By using a primary erythroid cell culture system, we show how differentiating 
erythroblasts are able to regulate iron-import, iron-storage and synthesis of 
protoporphyrin IX in a way that allows an optimal balance between these three 
processes. This is of special importance since an excess of iron or protoporphyrin IX 
would interfere with normal erythropoiesis due to their toxic properties. We could show 
that the main components of cellular iron metabolism are not expressed as the 
conventional iron regulatory system implies. This is caused by the coupling of iron import 
with its instant processing in the mitochondria, which leads to a virtually iron free cytosol 
despite increased iron acquisition during erythroid differentiation. Additional data 
generated with iron regulatory protein (IRP) deficient erythroblasts show that the two 
IRPs are of different relevance for the regulation of iron metabolism in the erythroid 
system, which allows a flexible and situation-dependent expression of the relevant 
proteins needed for heme synthesis during terminal erythroid differentiation. In addition 
to iron, oxygen has been shown to influence the activity of IRPs as well. This is 
particularly important with cell culture systems. In fact we could show that a reduction of 
oxygen supply affected the IRP activity in differentiating erythroblasts. Surprisingly, this 
effect was coupled to a reduced ability of the cells to differentiate properly and therefore 
was only indirectly caused by the low oxygen levels. Actually, we could show that low 
oxygen levels promote the proliferation of immature erythroblasts while an increase of 
the oxygen concentration allows terminal differentiation. This observation correlates with 
the in vivo situation in hematopoietic tissues. Immature progenitor cells reside in regions 
that are hypoxic whereas differentiating cells migrate to increasingly oxygenated areas 
the more mature they become. Consequently, changes of the oxygen supply of 
hematopoietic tissues allow the modulation of erythropoiesis directly, additionally to the 
indirect induction via erythropoietin. Furthermore, addition of the HIF-activator 
dimethyloxalylglycine resulted in the same effects observed with incubation at low 
oxygen levels. Therefore, we conclude that the activation of HIFs during systemic 
hypoxia is sufficient for a direct oxygen dependent regulation of erythropoiesis. 
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3. Introduction 
3.1. Hematopoiesis 
Hematopoiesis comprises the formation of leukocytes, erythrocytes and thrombocytes. 
These cells are required for the immune response, the oxygen transport and the blood 
coagulation in case of injury. Since blood cells in general have a limited life span, the 
organism is forced to continuously replenish lost cells. This is achieved by the self 
renewal and differentiating capacity of the multipotent long-term hematopoietic stem cells 
(LT-HSC)1. The self renewal capacity guarantees the survival of LT-HSCs in its niche as 
a source for all types of blood cells2. Differentiation leads to the formation of more 
committed cell types, starting with short-term hematopoietic stem cells that further 
differentiate into different types of multipotent progenitors (MPP) including lymphoid 
primed multipotent progenitor, the common myeloid or the common lymphoid progenitor 
(Figure 1), although the exact sequence and branching points of lineage commitment are 
still under discussion3. The MPPs further differentiate into different lineages and 
committed precursors and finally develop into fully differentiated mature blood cells. In 
general, the self renewal capacity of the hematopoietic cells decreases with each 
differentiation step. Furthermore, the entire process of hematopoiesis is dependent on 
the activity of several transcription factors that cooperate to regulate the decision 
between self renewal and differentiation1,4. The environment of the hematopoietic cells 
therefore plays a major role in their maintenance and differentiation by regulating the 
activities of these transcription factors3,5. This is also reflected in the change of the 
location of the hematopoietic tissue during development. The first organ of 
hematopoiesis in the murine embryo is the yolk sac, followed by the aorta-gonad 
mesonephros (AGM) region and the chorio-allantoic placenta6. Subsequently, 
hematopoiesis takes place in the fetal liver, followed by the bone marrow after birth. 
Each of these organs favors the production of specific blood cells. For instance, during 
the fetal liver phase the main part of hematopoietic capacity is focused on the production 
of erythrocytes in order to supply the growing embryo with sufficient amounts of oxygen. 
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Figure 1. Schematic overview of hematopoiesis with a detailed look at erythropoiesis. The long 
term hematopoietic stem cell (LT-HSC) is able to self renew or to differentiate in more mature 
hematopoietic precursor cells giving rise to all the hematopoietic lineages. As indicated by the 
arrows, the lineage commitment of early progenitors is not totally restricted but includes a certain 
degree of plasticity. For simplicity, the final steps of lineage differentiation are not shown in detail 
and involve several additional cell stages. The lower panel shows erythropoiesis in more detail, 
starting with the BFU-E and finally resulting in the formation of the mature erythrocyte.  
Figure adapted and simplified from Miranda-Saavedra and Göttgens, Current opinions in genetic 
and development65 20084 and A.Rad, Wikimedia.commons, 2011 
http://commons.wikimedia.org/wiki/File:Hematopoiesis_%28human%29_diagram.png 
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3.2. Erythropoiesis 
3.2.1. Ontogeny of erythropoiesis 
Erythropoiesis is a special branch of hematopoiesis and is responsible for the generation 
of red blood cells. Primitive erythropoiesis begins at embryonic day 7.5 (E7.5) in the yolk 
sack and guarantees the oxygen supply of the early developing embryo7. The first 
primitive erythroid cells enter the circulation around E8.5 with the onset of the heartbeat. 
Their maturation is still in progress after the release from the yolk sac into the circulation 
and comprises hemoglobin accumulation, globin type switching and enucleation8-10. At 
E9.5 yolk sac derived progenitor cells initiate the definitive erythropoiesis in the fetal 
liver11. By E11.5 they are displaced by HSCs of the AGM-region that continue with the 
production of red blood cells until erythropoiesis is transferred to the bone marrow after 
birth6,12.  
Definitive erythropoiesis in mammalians results in the production of erythrocytes 
that are characterized by a biconcave shape and the lack of the nucleus, mitochondria 
and other organelles13. Furthermore, they are packed with hemoglobin in order to carry 
out their function as oxygen transporters. The major part of the maturation process of 
definitive erythroblasts takes place in the hematopoietic organs and only enucleated 
reticulocytes are released into the blood stream to become mature erythrocytes14. The 
specialized anatomical unit of erythropoiesis within the fetal liver and the bone marrow is 
the so called erythroblast island15. It consists of one or two central macrophages 
surrounded by several erythroblasts. During maturation the erythroblasts migrate from 
the center of the island to its borders and finally are released into a blood sinusoid. 
During the last steps of this process the cell’s nucleus is released and endocytosed by 
the central macrophage. 
 
3.2.2. Erythroid development 
Erythropoiesis is part of the myeloid lineage of hematopoiesis. Therefore, the progenitors 
of erythroid cells are HSCs that differentiate into the common myeloid progenitor and 
subsequently into the megakaryocyte/erythroid progenitor. Further differentiation results 
in the blast forming unit erythrocyte (BFU-E; Figure 1), the first committed precursor that 
is restricted to the erythroid lineage. The BFU-E is dependent on the presence of stem 
cell factor (SCF) and erythropoietin (epo) and has a relatively high proliferation capacity: 
one single BFU-E can give rise to several thousand erythrocytes16,17. The BFU-E is 
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succeeded by the colony forming unit erythrocyte (CFU-E), a more committed progenitor 
that is dependent on the availability of epo and insulin or insulin-like growth factor 118-20. 
Further differentiation leads to the proerythroblast that is limited to 3-4 additional cell 
divisions, which result in the sequential formation of basophilic, polychromatic and 
orthochromatic erythroblasts21. The transition from the proerythroblast to the 
orthochromatic erythroblast includes cell size decrease, condensation of the nucleus, 
increased production of hemoglobin and changes in the membrane organization22,23. 
Finally, orthochromatic erythroblasts release the condensed nucleus and become 
reticulocytes that detach from the erythroblastic island and enter the circulation to 
become mature erythrocytes. 
 
3.2.3. Regulation of steady state and stress erythropoiesis 
The normal turnover of erythrocytes makes it necessary to constantly produce new red 
blood cells. Nevertheless, in special situations like embryonic development or during 
insufficient oxygen supply due to blood loss or caused by a transfer to elevated altitudes 
the demand for red blood cells becomes higher than provided by steady state 
erythropoiesis. In this situation the body reacts by increasing the production rate of 
erythrocytes, a process called stress erythropoiesis. This response is tightly regulated by 
the interplay of signals transmitted by the SCF receptor (c-Kit), the epo receptor (epoR) 
and the glucocorticoid receptor (GR)24,25.  
The epoR and epo are essential for definitive steady state as well as stress 
erythropoiesis and their deletion leads to death at E12.526,27. Upon binding of epo to the 
epoR, the epoR-associated Janus kinase 2 (Jak2) activates several signal cascades 
involved in the maturation of red blood cells28,29. This includes activation of the signal 
transducer and activator of transcription 5 (Stat5). The Bcl-2 gene family members Bcl-XL 
and Mcl-1 belong to the targets of Stat5 and prevent apoptosis of differentiating 
erythroblasts if activated by epo signaling30-32.  
SCF and its receptor c-Kit are essential for the development of several 
hematopoietic lineages and promote proliferation of hematopoietic progenitors. The 
absence of functional SCF or c-Kit causes severe anemia and premature death33. 
Regarding erythropoiesis, c-Kit mediated signaling stimulates expansion and delays 
differentiation of hematopoietic/erythroid progenitors including the BFU-E34. The SCF/c-
Kit complex activates the PI3K as well as the Ras/MAPK/ERK pathway. These signals 
are further enhanced by the formation of a joined signaling complex with the epoR, which 
Introduction 
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also activates these pathways, although less intensely26,35-37. Furthermore it has been 
shown that the Jak2 dependent activation of the epoR-target Stat5 is induced by c-Kit as 
well38. 
Glucocorticoids in combination with SCF and epo increase the proliferation 
capacity of erythroid cells and interfere with terminal erythroid differentiation39,40. Mice 
with a mutation of the GR that prevents binding of the transcription factor to its target 
sequence are viable and show normal steady state erythropoiesis41. However, these 
mice are not able to induce stress erythropoiesis during reduced oxygen supply 
indicating the importance of GR signaling under hypoxic conditions42. 
Taken together, the combination of SCF, epo and glucocorticoids induces stress 
erythropoiesis and can be used in vitro to establish cultures of proliferating primary 
erythroblasts that resemble BFU-Es and CFU-Es. These cells can be induced to undergo 
synchronous terminal differentiation by withdrawing SCF and replacing glucocorticoids 
by glucocorticoid-antagonists43. The close resemblance of this system to in vivo 
erythropoiesis makes it a perfect tool to analyze erythropoiesis as well as special 
aspects that are linked to this process.  
 
3.3. Iron metabolism 
Iron is essential for almost all cells due to its ability to easily transfer electrons in 
chemical reactions and therefore mediating catalytic reactions as well as due to its 
flexibility in the association with proteins and oxygen44. Hence, iron plays a crucial role in 
energy metabolism and DNA synthesis and is well known for its function in oxygen 
transport by hemoglobin in vertebrates. Nevertheless, the same abilities are also 
responsible for toxic effects, namely the generation of reactive oxygen species and other 
radicals, reactions that are summarized under the term Fenton chemistry45. Additionally, 
the oxidized trivalent form of iron (Fe3+) shows limited solubility in aqueous solutions and 
has to be sequestered by specific proteins in order to prevent accumulation of 
precipitates of iron in tissues and plasma. Therefore, iron uptake, utilization and storage 
have to be tightly regulated in order to prevent the occurrence of oxidative stress that 
would lead to damage of cellular macromolecules and tissue injury46.  
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3.3.1. Systemic Iron metabolism 
The major part of body iron can be found in erythrocytes and developing erythroblasts. 
More than 2.1 g circulate in the blood of an average adult human incorporated in 
hemoglobin47. Macrophages that are responsible for recycling of iron derived from 
senescent erythrocytes contain 0.6 g iron. Further 0.3 g can be found in muscle cells 
embedded in myoglobin. Excess iron is stored in the liver, where up to 1 g can 
accumulate in hepatocytes under normal non-pathological conditions48,49. The remaining 
iron is distributed over the different tissues of the body. Surprisingly, only 2.5-3 mg of 
iron are actually directly available for the organism in the form of iron saturated plasma 
transferrin (Tf-Fe2). This indicates the highly dynamic nature of the daily iron turnover, 
since 20-30 mg of iron, 10 times as much, are processed each day. As already indicated 
by the iron distribution in the body, the major part of the turnover is used for heme 
synthesis in developing erythroblasts (Figure 2). Under normal conditions, the body 
absorbs only 1-2 mg iron each day in the proximal small intestine since the iron needs 
are for the most part covered by the recycling and release of heme-bound iron of 
senescent erythrocytes. Iron absorption compensates for the iron loss caused by 
sloughing of intestine and skin cells as well as loss of iron associated with menstruation 
and the excretion of urine and bile. 
The body can import iron in the form of heme as well as non-heme iron. Both are 
absorbed at the apical brush boarder of intestinal enterocytes (Figure 2). In the case of 
heme import the corresponding transporter is not known. The only candidate up to date 
is the solute carrier 46A1 (SLC46A1) but its primary function seems to be folate and not 
heme transport50. After heme import, iron is separated from protoporphyrin by heme 
oxygenase 1 (HOX1) and enters the cytosolic iron pool of the enterocyte51. Non-heme 
iron import is performed by the divalent metal ion transporter 1 (DMT1, SLC11A2)52 and 
is dependent on the ferrireductase activity of duodenal cytochrome B (DcytB, CYBRD1) 
that transforms Fe3+ into Fe2+ 53,54. At the basolateral membrane of enterocytes 
ferroportin (SLC40A1) exports cytosolic Fe2+ into the circulation55,56. The export is linked 
to the oxidization of Fe2+ to Fe3+ by hephaestin that additionally allows the binding of iron 
to the plasma protein transferrin (Tf)57,58. 
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Figure 2. Systemic iron metabolism. Dietary iron is imported by duodenal enterocytes and 
released into the plasma were it binds to transferrin (Tf). The major part of the circulating iron is 
used by differentiating erythroblasts in order to synthesize heme whereas the iron consumption by 
all other tissues contributes less to the overall iron turnover. Senescent erythrocytes are recycled 
by splenic macrophages and their iron is released into the plasma, making the major contribution 
to the daily iron turnover while the duodenal iron import compensates for the systemic loss of iron 
caused by sloughing and bleeding (not shown). The liver has an iron storage function and 
releases iron if the body is confronted with iron deficiency. Furthermore, hepatocytes express 
hepcidin that induces the degradation of ferroportin in the case of iron overload and therefore play 
an important role in the regulation of systemic iron metabolism. For detailed description of distinct 
proteins see text. Figure adapted from Hentze et al., Cell 201059. 
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3.3.2. Cellular iron uptake and trafficking 
Tf is responsible for the iron supply of most of the cells within the body. The iron loaded 
form (Tf-Fe2) has a relatively high affinity for the transferrin receptor (TfR1) compared to 
the iron depleted form (apo-Tf) and is therefore preferentially bound. The Tf-Fe2/TfR1 
complex formation triggers clathrin dependent endocytosis and subsequent acidification 
of the endosomal compartment by proton pumps leads to a conformational change that 
releases Fe3+ from Tf but keeps the Tf/TfR1 complex intact60 (Figure 3). The 
ferrireductase Steap3 converts Fe3+ into Fe2+ and DMT1 transports iron across the 
endosomal membrane into the cytosol61. The Tf/TfR1 complex is redirected to the 
plasma membrane where the readjustment of the pH leads to the release of the iron 
depleted apo-Tf. While the TfR1 is now able to bind another Tf-Fe2, apo-Tf can be 
reloaded with Fe3+ released by enterocytes, hepatocytes or macrophages (Figure 2).  
 Tf/TfR1 independent import is limited to special cell types and physiological 
situations and therefore plays a minor role in general iron metabolism. Erythropoiesis for 
example is strictly dependent on iron supply by TfR1 as its targeted disruption leads to 
early lethality of murine embryos due to severe anemia62. Confirming the importance of 
the Tf/TfR1 pathway, TfR1+/- mice are not able to provide developing erythroblasts with 
sufficient amounts of iron and develop microcytic hypochromic anemia. Furthermore, Tf 
deficient humans and mice develop severe iron deficiency anemia63,64. Nevertheless it is 
still under discussion whether macrophage derived ferritin makes a contribution to the 
iron supply of developing erythroblasts65,66. A well known alternative route of cellular iron 
uptake that is restricted to macrophages is the already mentioned phagocytic recycling of 
senescent erythrocytes (Figure 3). Macrophages are also able to directly internalize 
heme (bound to plasma hemopexin)67 and hemoglobin (bound to haptoglobin)68. The iron 
supply through the blood brain barrier is not well understood but probably involves 
mechanisms comparable to the iron uptake in the duodenum69,70. Further alternative iron 
uptake pathways are connected to anti inflammatory reactions71,72 and pathological 
states linked to iron overload73 and extracellular ferritin74,75. 
The iron transport mechanisms within the cell are not well understood. When iron 
enters the cytosol it becomes part of the transient labile iron pool (LIP) that can be 
detected with the help of fluorescent sensors (reviewed in Breuer et al, 2008)76. The 
substances that bind iron of the LIP are still not defined but may include citrate, peptides, 
ATP or different phosphates. Nevertheless, the major part of cellular iron does not stay in 
the cytosol but is directed to mitochondria, where it is used for the synthesis of heme and 
iron sulfur clusters (Fe/S cluster; Figure 3). In yeast it has been shown that Grx3p and 
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Grx4p are essential for iron sensing in the cytosol and its transport to mitochondria77. It is 
still discussed whether differentiating erythroid cells bypass the cytosol by direct 
interaction of endosomes with mitochondria78 or use the conventional iron transport 
pathway involving the LIP79. The iron transporters mitoferrin1 (Mfrn1) and Mfrn2 are 
responsible for the mitochondrial iron import. Mfrn1 is essential for effective erythroid 
differentiation80 and is stabilized by the interaction with the erythroid specific ABC 
transporter Abcb1081. Mfrn2 is ubiquitously expressed but is not upregulated during 
increased mitochondrial iron demand and therefore cannot compensate for the loss of 
Mfrn1 that leads to severe defects in heme synthesis and Fe/S cluster assembly82.  
 
 
Figure 3. Cellular iron metabolism. Note that some of the components are only available and 
active in certain cell types, e.g. iron import in most cell types is dependent on the TfR1, while 
macrophages are able to phagocytose senescent erythrocytes and duodenal enterocytes 
transport dietary iron directly via DMT1. Furthermore, iron export of enterocytes is linked to the 
oxidative activity of hephaestin instead of ceruloplasmin. For further details see text. Figure from 
Hentze et al., Cell 201059. 
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3.3.3. Iron utilization – heme synthesis and Fe/S cluster assembly 
Mitochondria are responsible for the synthesis of heme and Fe/S clusters and therefore 
are the main consumers of cellular iron. Heme is not only needed for the transport of 
oxygen but is also part of several hemoproteins that are involved in oxidative 
metabolism, thyroid hormone synthesis and other cellular processes. The 
protoporphyrin/heme synthesis pathway starts with the reaction of succinyl-CoA with 
glycine that leads to the formation of δ-amino levulinic acid (ALA; heme synthesis and 
transport reviewed in Severance et al. 2009)83. This reaction is catalyzed by either of the 
two homologue enzymes ALA synthase 1 (ALAS1) and ALAS2 (ALAS-E)84-86. ALAS1 is 
ubiquitously expressed and responsible for the baseline synthesis of heme whereas 
ALAS2 expression is limited to erythrocytes and allows increased heme synthesis during 
erythropoiesis87,88. Furthermore, ALAS2 expression is linked to iron availability and 
connects heme synthesis with iron supply (see below). ALA is exported into the cytosol 
where it is processed to coproporhyrinogen III involving four sequential enzymatic 
reactions. Subsequently, coproporhyrinogen III is imported into mitochondria and 
oxidized to protoporphyrin IX (PPIX). In the last step of the heme synthesis pathway, 
ferrochelatase catalyzes the insertion of Fe2+ into PPIX. Heme is then incorporated into 
heme dependent proteins in mitochondria, the cytosol, the endoplasmatic reticulum and 
the nucleus. Little is known of the mitochondrial export of heme or of the transport of 
heme to the places of hemoprotein assembly. Since free heme is hydrophobic and 
cytotoxic it is postulated that it involves specific molecules and pathways89. 
 Fe/S clusters are part of several enzymes and proteins that are essential for 
electron transfer, energy metabolism, lipoate synthesis, nucleotide metabolism and iron 
metabolism90. The functions of the Fe/S clusters as part of these proteins include 
electron transfer, stabilization of protein structure and regulation of enzyme activity. The 
Fe/S cluster synthesis depends on a complex pathway involving several components 
and despite recent advances in the understanding of the cluster formation there still 
remain several open questions. There is evidence that the iron chaperone frataxin is 
responsible for the delivery of iron to the Fe/S cluster formation machinery although this 
issue is still controversial and the exact mechanism is not known91,92. Besides the Fe/S 
cluster assembly machinery in the mitochondria several homologue components of the 
machinery could also be detected in the cytosol and the nucleus. Although one model 
proposes totally independent de novo Fe/S cluster assembly machinery in the cytosol93 
there is evidence that cytosolic cluster assembly is dependent on the mitochondrial 
machinery94-98. Defects in the generation of Fe/S clusters result in deregulation of iron 
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metabolism and are linked to several diseases like Friedreich’s ataxia or X-linked 
sideroblastic anemia with cerebellar ataxia90,99. 
 
3.3.4. Cellular iron export and storage 
Ferroportin is the only known cellular exporter of elemental iron55,56. The function of the 
transporter is linked to ferroxidase activity of hephaestin in enterocytes and 
ceruloplasmin in all other cell types100. Disruption of ferroportin is embryonically lethal 
since the iron transfer via the extraembryonic visceral endoderm and the placenta is 
ferroportin dependent101. The targeted deletion of ferroportin that does not affect 
embryonic iron supply results in the accumulation of iron in macrophages, hepatocytes 
and duodenal enterocytes and leads to severe anemia, demonstrating the important role 
of ferroportin for systemic iron metabolism. Additionally to the cellular export of elemental 
iron, cells are able to export iron in the form of heme via FLVCR1102. The physiological 
function of this transporter is not well understood but it is linked to erythroid maturation 
and recycling of heme-iron by macrophages. 
 When the cellular iron demand is low, excess iron must be stored in a non toxic 
form within the cell. For this purpose the iron storage proteins ferritin H (FtH1) and ferritin 
L (FtL) assemble in a shell like structure containing 24 ferritin subunits103 (Figure 3). FtH1 
has an intrinsic ferroxidase activity while FtL contains a nucleation center that facilitates 
accumulation of excess iron. Up to 4500 Fe3+ ions can be stored in the form of ferric 
oxyhydroxide phosphate in a single ferritin cavity. Little is known about the transfer of 
iron from the LIP to the ferritin shell. It has been shown that Poly(rC)-binding protein 1 
promotes iron loading of ferritin in vitro and is essential for iron loading in cell culture 
experiments104. The importance of iron storage is underlined by the early embryonic 
lethality of FtH1 knock out mice105. Conditional deletion of FtH1 leads to liver damage 
and disturbed iron absorption in the duodenum106,107. Mutations of FtL are linked to 
neurodegenerative disorders due to increased iron dependent redox activity in the 
brain108. Remobilization of ferritin bound iron involves lysosomal turnover109 or is linked to 
ferroportin dependent export of iron that is followed by proteasomal degradation of iron 
depleted ferritin110,111. However, it has been shown that macrophages are not able to use 
ferritin bound iron as iron source for induced endogenous heme synthesis112. Ferritin can 
also be found in the serum and is used as a clinical marker of anemia since its levels 
correlate with tissue iron stores but are also increased during inflammation. It has been 
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shown that serum ferritin is excreted mainly by splenic macrophages and proximal tubule 
cells of the kidney113. 
An H-type ferritin isoform known as mitochondrial ferritin encoded by a nuclear 
intronless gene is targeted to mitochondria by an N-terminal leader sequence114. It is 
normally expressed at low levels but its expression is elevated in iron loaded 
erythroblasts (ring sideroblasts) during sideroblastic anemia115 and therefore is thought 
to protect mitochondria from toxic effects of excess iron.  
 
3.3.5. The two regulation systems of iron metabolism 
Iron is essential for several physiological functions in the organism but at the same time 
excess iron harms cells and tissues. Since there is no mechanism that allows the active 
excretion of iron, regulation of dietary iron import is the only possible way to control its 
total amount in the body. The central regulator of systemic iron metabolism is the 
peptide-hormone hepcidin (reviewed by Nemeth and Ganz, 2009)116. Hepcidin is 
produced in the liver as an 84 amino acid propeptide that is cleaved into its 25 amino 
acid active form, which is then released into the blood117. It inhibits cellular iron export by 
binding to the iron transporter ferroportin. The complex formation triggers its own JAK2 
dependent phosphorylation followed by internalization and lysosomal degradation118,119. 
Thus, if hepcidin levels are high, nutritional iron cannot enter the plasma since it is 
literally trapped within duodenal enterocytes that are removed through naturally 
occurring sloughing in the intestine within several days. Iron stores in hepatocytes and 
heme derived iron recycled by macrophages are retained by the same mechanism in 
order to reduce plasma iron levels120,121. Pathologically reduced levels of hepcidin result 
in iron overload or hemochromatosis and consequently lead to liver cirrhosis, cancer, 
diabetes, hypogonadism, heart failure and arthritis if not treated by iron depletion 
therapy122. Pathologically high levels of hepcidin result in iron deficiency anemia123,124. 
The expression of hepcidin is regulated transcriptionally and integrates signals of 
systemic iron supply122,125,126, inflammation127-129, oxidative stress130 and erythropoiesis131-
133. The pathways involved in the transduction of these signals include the BMP6/SMAD 
and the C/EBPα pathways as well as STAT3 and TLR4 signaling.  
Additional to the hepcidin-dependent regulation of systemic iron metabolism, the 
posttranscriptional regulation of cellular iron uptake, storage and utilization is mediated 
by the iron regulatory protein 1 (IRP1; ACO1) and IRP2 (IREB2)47,59. The IRPs are able 
to bind to cis-acting hairpin structures of their target mRNAs, the iron responsive 
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elements (IRE). IREs are conserved in the majority of metazoa134 and up to date have 
been found in the 3’ untranslated region (UTR) of TfR1135, DMT1136, myotonic dystrophy 
kinase-related Cdc42-binding kinase α137 and human Cdc14A138 as well as in the 5’ UTR 
of ferritin H and L139, ferroportin140, ALAS286, mammalian mitochondrial aconitase141, 
drosophila succinate dehydrogenase142, Alzheimer amyloid precursor protein143, α-
synuclein144 and HIF2α145. IRP binding to 3’ UTR IREs results in the stabilization of the 
corresponding mRNA whereas binding to the 5’ UTR IREs interferes with translational 
initiation (Figure 4). The canonical IRE contains a conserved loop (CAGUGN) and a 
variable stem-sequence146. The α-helix formed by the stem is distorted by an unpaired C-
bulge or a UGC/C-bulge/loop in the case of ferritin mRNA147,148. HIF2α and DMT1 
mRNAs contain a non canonical IRE with an additional bulge in the upper stem. The C-
bulge and the loop directly interact with the IRPs149 but there is also evidence for 
variation of IRP1 binding affinity dependent on the stem sequence150.  
 The IRPs belong to the family of iron-sulfur-cluster isomerases and are closely 
related to the mitochondrial aconitase, which is responsible for the conversion of citrate 
to isocitrate during the citric acid cycle151. The bifunctional IRP1 becomes the cytosolic 
isoform of the mitochondrial aconitase when it binds a 4Fe-4S cluster. Simultaneously, 
this inhibits the interaction with IREs, since the binding sites for the IRE and the Fe/S 
cluster overlap149,152. Therefore, the switch between IRE binding and aconitase activity is 
dependent on iron availability and a functional mitochondrial Fe/S cluster synthesis. IRP2 
shares large homology with IRP1 but does not bind a Fe/S cluster and has no aconitase 
activity. In fact, the IRE binding activity of IRP2 is regulated by proteasomal degradation 
initiated by iron dependent ubiquitination. The F-box and leucine-rich repeat protein 5 
(FBXL5), which is part of an E3 ubiquitin ligase complex, is responsible for the 
ubiquitination 153,154. FBXL5 contains a hemerythrin domain with a Fe-O-Fe center 
making its function dependent on the availability of iron and oxygen. If iron levels are 
high, the enzyme is active and ubiquitination of IRP2 takes place. Upon iron depletion 
FBXL5 loses its functionality and becomes degraded.  
 In addition, IRPs are also responsive to non-iron signals. As already indicated 
above, hypoxia favors stabilization of IRP2 but also of Fe/S clusters, thereby decreasing 
IRP1 binding activity155. Reactive oxygen and nitrogen species activate IRP1 binding 
activity by destabilizing the bound Fe/S cluster156 and there is evidence that nitric oxide 
as well as oxidative stress stabilize IRP2157,158. Furthermore, both IRPs are targets for 
specific phosphorylation influencing their binding activity and stability159-162. Taken 
together, these regulatory mechanisms allow the fine tuning of IRP binding activity 
additional to the regulation by iron availability. 
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 The importance of IRP dependent regulation of cellular iron metabolism is 
demonstrated by IRP1/IRP2 double deficient mice that die during embryonic 
development at the blastocyst stage163. Targeted deletion of both IRPs in the duodenum 
results in intestinal mal-absorption and death within 4 weeks after birth164. In these mice 
iron import of enterocytes via TfR1 and DMT1 is decreased whereas iron storage by 
ferritin H and L as well as iron export by ferroportin are increased leading to cellular iron 
depletion and intestinal dysfunction. Mice with IRP deficient livers show mitochondrial 
iron deficiency and dysfunction of hepatocytes165. This leads to compromised heme and 
Fe/S cluster synthesis and premature death due to liver failure. IRP1 and IRP2 single 
knockout mice are both viable and fertile showing that their function is essential but 
partly redundant. IRP1 deficiency shows no pathological phenotype besides 
misregulation of ferritin and TfR1 expression in the kidney and brown fat tissue166. IRP2 
knockout mice develop a mild microcytic anemia and show excessive iron deposits in the 
duodenum and the liver as well as iron deficiency in the spleen167,168. Furthermore, these 
mice also show a tendency for neurodegeneration linked to accumulation of iron in the 
brain169. The severity of this neuropathology is still under discussion and may be 
influenced by different target strategies170,171. Targeted deletion of IRP2 in enterocytes, 
hepatocytes or macrophages only affects the intrinsic iron metabolism of the respective 
cells and does not alter plasma iron levels indicating that microcytic anemia in IRP2 
knockout mice is a cell autonomous effect as well172.  
 Although the involved mechanisms of activation and action are different, the 
cellular regulators IRP1 and IRP2 and the systemic regulator hepcidin do not operate 
isolated from each other59. They both control the uptake of dietary iron as well as the 
release of iron into the plasma by directly regulating the abundance of ferroportin. The 
expression of hepcidin itself is modulated by the IRP-controlled iron availability in 
hepcidin-producing hepatocytes. Furthermore, the HIF transcription factors regulate the 
expression of hepcidin, ferroportin and DMT1173,174 whereas HIF2α expression is 
controlled by IRP binding activity145. A fourth connection between the two regulatory 
systems is TfR1. The expression of the receptor is regulated by the IRE/IRP system but 
the receptor itself interacts with the HFE protein, which participates in the systemic iron 
status mediated control of hepcidin expression175,176. Since the regulation of hepcidin 
expression is still not fully understood and additional IRP targets are likely to be found, 
further connections may be revealed in the future. Nevertheless, the above mentioned 
mechanisms already illustrate the complexity and importance of proper iron regulation in 
each single cell as well as in the whole organism. 
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Figure 4. The IRE/IRP system – regulation of cellular iron metabolism. Iron deficiency increases 
the binding activity of IRPs and results in the downregulation of mRNAs containing a 5’ IRE (e.g. 
ferritin or ALAS2) due to inhibition of translational initiation. 3’ IRE-containing mRNAs (e.g. TfR1) 
are stabilized leading to increased expression of the corresponding proteins. If sufficient iron is 
available, the IRP1 binding activity is blocked by the incorporation of an iron sulfur cluster while 
IRP2 is degraded resulting in unbound IREs. This leads to the translation of 5' IRE-containing 
mRNAs while 3' IRE containing mRNAs become accessible to degradation. See text for further 
details. 
 
3.4. Oxygen and the organism 
Oxygen is one of the most abundant elements in our environment. It does not only 
contribute 21% to the earth’s atmosphere but also can be found in large amounts in the 
lithosphere, the oceans as well as the biosphere of our planet. Furthermore, the 
circulation of oxygen between the biosphere and the atmosphere is very dynamic due to 
the oxygenic photosynthesis performed by cyanobacteria, green algae and terrestrial 
plants. In fact, the light-powered splitting of water is responsible for the high amount of 
oxygen in the atmosphere177. When more than two billion years ago free elemental 
oxygen first appeared in the oceans and subsequently in the atmosphere, the anaerobic 
organisms where confronted with an increasingly oxidizing environment178. Since the 
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aggressive properties of elemental oxygen and its derivates are a constant source of cell 
damage, only the development of antioxidant systems including the enzymes superoxide 
dismutase and catalase allowed the survival under these conditions179. Nevertheless, the 
abundant availability of oxygen led to an enormous improvement of energy metabolism 
since oxygen can be used as the final electron acceptor during the generation of ATP via 
oxidative phosphorylation180. In fact, most mitochondria containing eukaryotes as well as 
many bacteria and archaea use this mechanism and moreover, higher eukaryotes are 
even dependent on this form of ATP generation and therefore must guarantee sufficient 
oxygen supply. Unicellular as well as less complex organisms can realize this by simple 
diffusion but higher organisms like vertebrates additionally need a sophisticated 
respiratory/circulatory system. The oxygen transport in vertebrates is achieved by the 
bloodstream. For this purpose the blood contains erythrocytes that consist mainly of 
hemoglobin in order to bind higher amounts of oxygen than normally could be dissolved 
in the plasma alone. The gradient between inbreathed air and the blood within the 
capillaries surrounding the alveoli causes the diffusion of oxygen to oxygen depleted red 
blood cells. The oxygen is released again, when the erythrocytes that are transported by 
the cardiovascular system reach peripheral tissues. Following the concentration gradient 
it diffuses to the site of oxidative phosphorylation, the mitochondria. 
 
3.4.1. Oxygen sensing 
The carotid body is the organ that monitors the oxygen supply of the mammalian 
organism as a whole181. It is situated near the fork of the common carotid artery and 
senses not only the oxygen pressure but also the carbon dioxide pressure, the glucose 
level and the pH value in the blood182. The exact mechanisms that are involved in the 
sensing of oxygen levels by the carotid body are still under investigation and include 
functions of mitochondria and the cellular membrane of glomus cells. These cells release 
neurotransmitters that directly induce signaling to the medulla oblongata, the region of 
the brainstem that regulates oxygen supply relevant parameters like ventilation and heart 
rate. The carotid body responds to very small changes in oxygen tension of the arterial 
blood and is very fast in inducing changes of the cardiovascular and respiratory systems. 
Therefore, it is perfectly adapted to respond to acute changes of oxygen supply induced 
by increased physical activity. 
The cardiovascular system transports oxygen to every tissue of the body but, 
dependent on variable metabolic activity and the distance of cells to blood vessels, the 
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oxygen supply of cells varies within the tissues and can even decrease to suboptimal 
levels. Therefore, each individual cell has certain mechanisms enabling it to sense 
reduced oxygen levels and result in short/long term adaption to this special situation 
involving cellular and systemic mechanisms. The sensing systems can be divided into 
bioenergetic and biosynthetic mechanisms. Bioenergetic mechanisms involve 
perturbations of the mitochondrial function and the energy state of the cell including the 
redox state and the change of reactive oxygen species production. Biosynthetic sensing 
mechanisms include the oxygen dependent function of different enzymes, like NADPH 
oxidases, heme oxygenases, cytochrome P-450 monooxygenases and 2-oxoglutarate 
and iron(II)-dependent dioxygenases183. The dioxygenases are responsible for the 
regulation of the transcriptional response to reduced oxygen levels (see below). 
 
3.4.2. Transcriptional response to hypoxia – HIF 
The transcriptional response to reduced oxygen supply plays an essential role in the 
cellular and also in the systemic adaption to hypoxia. The central components of this 
response in vertebrates are the hypoxia inducible factors (HIFs). HIFs were identified as 
transcription factors that induce the expression of epo184 in specialized cells of the kidney 
and to a lesser extent in the liver and the brain23,185,186. Today, more than 100 target 
genes are known to be directly modulated by the activity of HIFs emphasizing its 
importance during hypoxia187. The transcription factor binds to DNA at the so called 
hypoxia response element (HRE) that contains an RCGTG consensus sequence. The 
expression of HIF target genes affects metabolic adaption, erythropoiesis, angiogenesis, 
vascular tone, cell growth, differentiation, survival and apoptosis188. There is also 
evidence that the HIF-regulated expression of certain microRNAs189-191 as well as of 
histone demethylases192,193 may further broaden the signaling output of the HIF 
transcription factors. 
 HIFs are heterodimeric proteins, consisting of an α-subunit that is induced by 
hypoxia and a β-subunit that is constitutively expressed. Both subunits are basic helix-
loop-helix (bHLH) proteins and are part of the PAS domain (Per; AHR; ARNT; SIM) 
protein family194. In mammalians there are three HIF-α proteins that are encoded by 
distinct gene loci (Figure 5). HIF-1α was the first HIF-α subunit identified and is widely 
expressed in normal tissues184. HIF-2α was identified in endothelial cells but is also 
expressed in parenchyma and interstitial cells of multiple organs195,196. While HIF-1α and 
HIF-2α share a similar domain structure, HIF-3α is less closely related197. Its function is 
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not well understood, although it has been shown that an alternative splicing variant 
leading to a shorter version of the protein called inhibitory PAS domain protein (IPAS) 
forms transcriptionally inactive heterodimers with HIF-1α198. This and more recent data 
indicate that HIF-3α may be of relevance for the regulation and fine tuning of the 
transcriptional activity of HIFs199 (Figure 5). In addition to the already mentioned bHLH 
and PAS domains that are essential for DNA binding and dimerization, HIF-α proteins 
contain transactivation domains (TAD) that are involved in the recruitment of other 
transcription factors200. During hypoxia, the C-terminal-TAD (C-TAD) is able to interact 
with the CH-1 domain of the transcriptional coactivator p300/CBP201. This interaction is 
sterically inhibited by the oxygen dependent hydroxylation at an asparaginyl residue202,203 
(see below). Further oxygen dependent regulation is mediated by the two oxygen 
dependent degradation domains (N-terminal, N-ODD and C-terminal, C-ODD)204,205, 
each of which contains a prolyl residue that is hydroxylated if oxygen is present206,207. 
The hydroxylated prolyl residues trigger the interaction with the von Hippel-Lindau tumor 
suppressor protein (pVHL) that is part of an E3 ubiquitin ligase complex which 
ubiquitinates the HIF-α proteins at several sites leading to proteasomal degradation208. 
Additionally, several other factors influencing the activity of HIFs besides hydroxylation 
are known to date, but their physiological relevance is still under discussion209.  
The HIF-1β proteins, also known as aryl hydrocarbon receptor nuclear 
translocators (ARNT1, 2 and 3) contain a bHLH and a PAS domain but lack the ODDs 
making them insensitive to oxygen supply194,210,211. HIF-1β forms heterodimers with HIF-α 
proteins as soon as the latter are stabilized under hypoxic conditions. 
 Knock out studies have shown that HIF-1α as well as HIF-2α are both essential 
for normal embryogenesis. Interestingly, inactivation of either one of the two proteins 
leads to different phenotypes, indicating their non redundant functions in the organism. 
HIF-1α negative mice die around E10.5 and these embryos show defective 
vascularization and cardiac morphogenesis212. Furthermore, heterozygous or tissue 
specific loss of HIF-1α function has revealed the importance of this transcription factor 
for hypoxic adaption and also for physiological functions in different cell types as well as 
for tumor survival188,213-215. The phenotype of HIF-2α inactivation has been shown to be 
dependent on the genetic background. Whereas the first established knock out mice died 
in utero (E9.5-13.5) due to defective catecholamine production and vascularization216,217 
backcrossing into different mouse strains resulted in a small number of viable adult mice 
that suffer from multiple organ pathology, metabolic abnormalities and impaired 
homeostasis of reactive oxygen species218. The distinct phenotypes of HIF-1α and HIF-
2α deficient mice demonstrated that the two transcription factors have unique targets. 
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Further studies that addressed the question of specific transcriptional activation in more 
detail revealed that HIF-1α is responsible for the hypoxic dependent regulation of several 
glycolytic enzymes, carbonic anhydrase and BNIP-3219-221 whereas HIF-2α induces the 
expression of Oct4, cyclin D1, TWIST1, TGF-α and epo amongst others222-226. Finally 
there are also genes like VEGF, adrenomedullin and GLUT-1 that are regulated by both 
transcription factors219,227. In general, HIF-1α and HIF-2α bind to HREs equally well and 
consequently this does not play a major role in specificity of transcriptional induction228. 
In fact, it could be shown that the C-terminal domains, which mediate the interaction with 
other transcription factors, are responsible for the target specificity of HIFs229,230. Further 
investigation is needed to fully understand the mechanisms determining the distinct 
targets of both HIFs that may include interaction with other transcription factors, signaling 
cascades and the local chromatin status. 
 
Figure 5. Domain structure of HIF family members. All HIF proteins contain a bHLH domain 
needed for DNA binding and two PAS domains involved in dimer-formation. The HIF-α subunits 
additionally contain an oxygen dependent degradation domain (ODD) making these proteins 
sensitive to high oxygen levels. The initial signal for HIF-1α degradation is the hydroxylation of 
two proline residues of this domain. Within the ODD lies the N-terminal activation domain (NTAD) 
that is involved in the interaction with other transcription factors. The C-terminal activation domain 
(CTAD) of HIF-1α and HIF-2α contains an asparaginyl residue that is hydroxylated as well when 
oxygen is available, inhibiting the interaction of the CTAD with transcription factors like p300. 
IPAS is a splice variant of HIF-3α and is assumed to be involved in the regulation of HIF activity. 
HIF-1β or ARNT lacks the ODD and therefore is insensitive to oxygen dependent degradation. 
Together with the HIF-α subunits HIF-1β forms heterodimers, i.e. functional HIF transcription 
factors. Figure adapted from Lisy and Peet, Cell Death and Differentiation, 2008231.  
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3.4.3. Regulation of HIF-α by oxygenases – PHDs and FIH1 
As already mentioned above, the oxygen dependent hydroxylation of a specific 
asparagyl residue interferes with the interaction of the HIF-α C-TAD with p300/CBP, 
thereby reducing its activity as transcription factor. Furthermore, hydroxylation of either 
one or both of two prolyl residues triggers the proteasomal degradation of HIF-α by 
promoting pVHL dependent ubiquitination (Figure 6). Both modifications are catalyzed by 
hydroxylases that belong to the family of 2-oxoglutarate and iron(II)-dependent 
dioxygenases231,232. As indicated by the name, the activity of these enzymes depends on 
the availability of ferrous iron that is situated in the enzymatic center of the proteins233,234. 
There it is involved in the transfer of one oxygen atom of O2 to the target amino acid 
whereas the second atom is transferred to 2-oxoglutarate, which leads to the formation 
of succinate and CO2. Therefore, besides low oxygen levels, chelating or replacing iron 
by other metal ions like cobalt as well as the replacement of 2-oxoglutarate by structural 
homologues like dimethyloxalylglycine (DMOG) inhibit oxidase activity and consequently 
stabilize and activate HIFs207,235.  
The two proline residues are hydroxylated by HIF prolyl hydroxylases (PHDs) that 
belong to the larger family of prolyl-4-hydroxylases236. In mammalians there are three 
isoforms described: PHD1-3237. PHD2 is the most abundant isoform whereas PHD1 and 
PHD3 expression is restricted to specific tissues like testis and heart238. Moreover, PHD2 
prefers HIF-1α as substrate, while PHD1 and PHD3 prefer HIF-2α239. Differences in 
tissue distribution and different contribution to the regulation of the two HIFs may 
therefore partly explain the observed target specificity of HIF-1α and HIF-2α. Recently, 
P4H-TM, a prolyl-4-hydroxylase that is located in the endoplasmatic reticulum 
membrane, has been shown to hydroxylate HIFs as well but its physiological importance 
for the regulation of HIFs is still under investigation240.  
 In contrast to prolyl hydroxylation, asparaginyl hydroxylation is performed by one 
single enzyme called factor inhibiting HIF (FIH)202,241,242. FIH is ubiquitously expressed 
and predominantly localized in the cytoplasm243,244. Interestingly, in vitro data showed 
that the KM values of PHDs for oxygen are higher than those of FIH indicating that FIH is 
still active when prolyl hydroxylation is already absent due to reduced oxygen 
levels245,246. Therefore, in a mild hypoxic environment C-TAD mediated transcriptional 
activation by p300/CBP is still blocked although the HIF proteins are already stabilized 
and the N-TAD is active231. Generally, the KM values for oxygen of all hydroxylases 
involved in HIF-α regulation are relatively high compared to physiological oxygen 
concentrations. Hence, the change of hydroxylase activity is highly dynamic over the 
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whole physiological range of oxygen concentrations and allows immediate reaction to 
even very small changes of oxygen supply183,247,248. 
 
Figure 6. Regulation of HIF activity. Under hypoxic conditions HIF-α subunits form dimers with 
HIF-β subunits and induce the transcription of HRE regulated genes by the interaction with other 
TFs like p300. However, if oxygen is available, HIFs are hydroxylated by FIH and PHD1-3, which 
leads to transcriptional inactivation and eventually ubiquitination of the protein. The ubiquitinated 
HIF-α proteins are recognized and degraded by the proteasomal complex. See text for more 
details.  
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3.4.4. Oxygen distribution in the mammalian body 
In order to provide all cells of the body with oxygen, higher organisms have developed 
sophisticated transport systems using convection as the driving force. In the case of 
mammalians this system consists of the respiratory tract and the cardio-vascular system. 
Nevertheless, the oxygen supply is also dependent on diffusion that allows the transition 
of oxygen through the alveolar-capillary membranes as well as from the blood to 
mitochondria, the main oxygen consumers. Due to the cell type dependent equilibrium 
between delivery and consumption the oxygen concentration of different tissues as well 
as within a tissue itself shows considerable variation183. The lung parenchyma are 
obviously relatively well supplied with oxygen due to the direct contact to atmospheric 
oxygen levels of 20-21%249. Accordingly, the arterial blood that leaves the lungs still 
contains about 14% oxygen but the oxygen concentration steadily decreases to about 
4% when it reaches the capillaries of the most peripheral tissues250,251. Therefore, the 
range of oxygen concentration within organs that are well supplied with arterial blood like 
the liver and the heart are comparable to the concentrations measured within the blood 
itself. However, the combination of constant oxygen consumption and increased distance 
to the capillaries leads to a lower oxygen concentration at least in some regions 
especially of less well irrigated tissues. Measurements of the brain oxygenation showed 
that depending on the observed region, the oxygen concentration lies between 0.5% and 
7%252,253. Comparable results could be obtained for the bone marrow although the levels 
here are even lower, lying between 0% and 5%254,255. Chow et al. further addressed the 
question of oxygen distribution in the bone marrow based on the Kroghian model in more 
detail256-259. Founded on their calculations they could show that hematopoietic 
progenitors are localized in regions of the bone marrow with very low oxygen tension. 
Furthermore, the oxygen concentration within smaller structures like the erythroblastic 
island becomes reduced towards the center and increased maturity of the erythroblasts 
correlates with increased oxygen tension. This correlation of tissue oxygen concentration 
and maturity of hematopoietic cells doesn't seem to be a coincidence but can contribute 
to the decision between self renewal and differentiation. In fact, it has been shown that 
low oxygen levels support the maintenance of stem cells and enhance the self renewal 
capacity of early progenitor cells of several lineages including erythroblasts260-265. The 
underlying mechanisms are still unknown and may be linked to the reduced formation of 
ROS or the hypoxia induced expression of certain growth factors and cytokines266. 
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Figure 7. Distribution of oxygen concentrations in the cardiovascular system and tissues. The 
rectangles represent variation of the available data. Note that in some cases the oxygen 
concentration in tissues and the cytosol is lower and can even drop to zero. For further details see 
text. Figure simplified from Ward, Biochimica et Biophysica Acta 2008183. 
 
3.4.5. Oxygen and tissue culture 
As mentioned above, the oxygen concentration plays an important role in the fate of cells 
in vivo. During the in vitro culture of cell lines or primary cells this is of equal relevance. 
In fact, it is crucial for the work with in vitro cultures to establish conditions that resemble 
the physiological situation, since inadequate oxygen supply may affect the cultivation of 
the cultivated cells in general and in addition, may influence the specific mechanisms 
that are analyzed. Nevertheless, the standard tissue culture incubator does not allow the 
adjustment of the oxygen concentration but uses the ambient atmosphere containing 20-
21% oxygen supplemented with CO2. In addition, the use of conventional polystyrene 
dishes in tissue culture limits the oxygen supply of the cells by one dimensional diffusion 
through the culture medium. This is physically described by Fick’s first law of gas 
diffusion that adapted to tissue culture conditions says that: 
 
𝑑𝑈𝑜𝑥𝑦
𝑑𝑡
= −𝐷𝐴𝐶𝑔𝑎𝑠 − 𝐶𝑐𝑒𝑙𝑙
ℎ
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where dUoxy/dt is the quantity of oxygen transported from the top to the bottom of the 
culture dish in a period of time, D is the diffusion constant of the medium, A is the area of 
diffusion, Cgas is the oxygen concentration defined by the composition of the incubator 
atmosphere, Ccell is the oxygen concentration at the bottom of the dish (i.e. pericellular 
oxygen concentration) and h is the diffusion distance from the top to the bottom of the 
dish267. Several papers that addressed the problem of oxygen supply in tissue culture on 
the basis of this equation came to the conclusion that several cell types that are 
cultivated at 20% oxygen under conventional conditions are indeed facing a severely 
hypoxic environment since the oxygen consumption rate exceeds the diffusion rate 
through the culture medium268-270. Metzen et al. confirmed these estimations by 
comparing the calculations with direct measurements of the pericellular oxygen 
concentration271. Despite these observations, some cell culture studies that address 
oxygen dependent mechanisms are performed at reduced levels of ambient oxygen. 
These levels were chosen to resemble the oxygen concentration in the corresponding 
tissue in order to ensure physiological conditions. In view of the fact that atmospheric 
oxygen levels are often insufficient to allow adequate oxygen supply in tissue culture, 
further reduction of the oxygen concentration rather leads to the establishment of 
severely hypoxic conditions that eventually result in artificial results. Thus, tissue culture 
experiments must be performed under consideration of the cell type, the state of 
confluence, the metabolic activity, the diffusion distance and the oxygen fraction of the 
incubator atmosphere in order to ensure reliable results267.  
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4. Aims of this work 
Although erythropoiesis is a well studied process there are still several open questions to 
be addressed. The formation of red blood cells is dependent on the import and handling 
of exceptionally increased amounts of iron but since an excess of iron is toxic this 
requires stringent regulation. In non erythroid cells this is perfectly accomplished by the 
IRE/IRP system. Nevertheless, with erythroid cells the situation is more complex. IRP 
binding activity regulates the equilibrium between iron import by TfR1 and iron storage 
by ferritin47. During terminal erythroid differentiation iron accumulates within the cell, 
which conventionally leads to a decrease of iron import and increased storage of iron 
within ferritin shells and would interfere with normal heme synthesis. An additional 
aspect that contributes to the complexity of the situation is the IRP dependent 
posttranscriptional regulation of the erythroid specific enzyme ALAS2. ALAS2 and ferritin 
contain both an IRE within their 5’UTR indicating synchronous posttranscriptional 
regulation. Nevertheless, during the period of heme synthesis the expression of ferritin 
needs to be low in order to prevent iron sequestration while the increased expression of 
ALAS2 is essential for protoporphyrin synthesis. We addressed the question how 
erythroid cells accomplish to maintain sufficient iron supply during differentiation using an 
erythroid culture system that is perfectly suited to analyze system intrinsic processes 
under in vivo-like conditions43. 
 The analysis of IRP1 and IRP2 deficient mice has shown that the lack of IRP1 
does not affect erythropoiesis whereas IRP2 knock out mice show microcytic anemia, at 
least under laboratory conditions167,168. Since the targeted deletion of IRP2 in 
macrophages, hepatocytes and enterocytes shows no erythroid related phenotype, this 
indicates that the observed anemia of IRP2 deficient mice is an inherent erythroid 
phenotype172. We were interested in the specific contribution of IRP1 and IRP2 on the 
regulation of ferritin and TfR1 expression in our erythroid culture system that allows the 
analysis of the anemic phenotype in more detail. Hence, with this system we are not only 
able to modulate heme synthesis and the iron household of the cells but can also 
monitor the differentiation of IRP1 and IRP2 deficient erythroblasts in a defined 
environment, making it possible to investigate the intrinsic effects of disturbed IRP 
activity. 
 The oxygen concentration is known to influence the binding activity of IRPs as 
well as the process of erythroid differentiation. The latter is not only affected indirectly by 
hypoxia dependent expression of epo but also directly by a still less well understood 
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mechanism. Nevertheless, the classical cultivation of cells within incubators does not 
consider the adjustment of the oxygen concentration to physiological levels.  In order to 
minimize artificial effects on the outcome of our work due to inappropriate oxygen supply 
we were interested in the influence of changed oxygen concentration on the iron 
regulatory system as well as on the proliferation and differentiation of cultivated 
erythroblasts. Furthermore, we addressed the question, which mechanism is relevant for 
the direct influence of oxygen on erythropoiesis.  
Results 
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5. Results - Manuscripts 
The data presented in the result section are 
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5.1.1. Abstract 
 
Terminal erythropoiesis is accompanied by extreme demand for iron to ensure proper 
hemoglobinization. Thus, erythroblasts must modify the "standard" post-transcriptional 
feedback regulation, balancing expression of ferritin (Fer; iron storage) versus transferrin 
receptor (TfR1; iron uptake) via specific mRNA binding of iron regulatory proteins (IRPs). 
Although erythroid differentiation involves high levels of incoming iron, TfR1 mRNA 
stability must be sustained and Fer mRNA translation must not be activated because iron 
storage would counteract hemoglobinization. Furthermore, translation of the erythroid-
specific form of aminolevulinic acid synthase (ALAS-E) mRNA, catalyzing the first step of 
heme biosynthesis and regulated similarly as Fer mRNA by IRPs, must be ensured. We 
addressed these questions using mass cultures of primary murine erythroid progenitors 
from fetal liver, either undergoing sustained proliferation or highly synchronous 
differentiation. We indeed observed strong inhibition of Fer mRNA translation and 
efficient ALAS-E mRNA translation in differentiating erythroblasts. Moreover, in contrast 
to self-renewing cells, TfR1 stability and IRP mRNA binding were no longer modulated by 
iron supply. These and additional data stemming from inhibition of heme synthesis with 
succinylacetone or from iron overload suggest that highly efficient utilization of iron in 
mitochondrial heme synthesis during normal erythropoiesis alters the regulation of iron 
metabolism via the IRE/IRP system. 
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5.1.2. Introduction 
 
Maturing erythroid progenitors require large amounts of iron to enable high rates of heme 
synthesis. The daily generation of about 20 g erythrocytes in adult humans requires the 
delivery of 20 mg iron via iron-loaded transferrin (Fe2-Tf) to the bone marrow. The 
corresponding transferrin receptor (TfR1) is highly expressed on the cell surface of 
erythroblasts. Recently, a second variant, TfR2, was characterized, which among other 
cells is also found on the surface of immature erythroid cells1,2, but seems to play a minor 
role during terminal maturation2,3. Tf-TfR1 complexes are internalized into endosomes 
via receptor-mediated endocytosis, and endosome acidification leads to release of iron4,5 
and, subsequently, to its export into the cytoplasm via the transporter DMT-16,7. Finally, 
iron is delivered to its sites of utilization; any excess gets stored in ferritin (Fer). This 
sequestration is important to avoid oxidative damage via this highly reactive metal. 
Therefore, the balance between iron uptake, utilization, and storage has to be tightly 
regulated.  
Cis-acting elements involved in this control are the stem-loop structures called 
iron regulatory elements (IREs) in several mRNAs (for a review, see Pantopoulos8). Such 
IREs are found in the 5'-untranslated region (UTR) of ferritin light (FerL) and heavy chain 
(FerH) mRNA, and in 5 copies within the 3'-UTR of TfR1 mRNA. These elements are 
recognized by trans-acting factors, that is, iron regulatory proteins 1 and 2 (IRP1, IRP2), 
which bind with high affinity to IREs in their cognate mRNAs. One difference between 
IRP1 and IRP2 lies in their mode of regulation. IRP1 is a bifunctional protein, which 
under high iron releases the IRE, incorporates a cubane 4Fe-4S cluster, and gains 
enzymatic activity as cytosolic aconitase9. In contrast, IRP2 mRNA-binding activity is 
turned off by proteasomal degradation10-12. 
In a generally accepted "standard" model, cytosolic iron concentrations regulate 
the mRNA-binding activity of IRP1/2 to IREs, which are localized in the UTRs of a 
growing number of transcripts8. IRPs bind to IREs under low iron concentrations, which, 
for example, inhibits translation of Fer messages13,14 and stabilizes TfR1 mRNA15-17. 
Consequently, cellular iron uptake is stimulated18,19, whereas storage is inhibited. At high 
iron concentrations, IRP1 incorporates iron-sulfur clusters and thus does not bind target 
mRNAs while IRP2 gets degraded10-12. This leads to an increase in Fer synthesis and 
TfR1 mRNA degradation via a specific endonuclease pathway15-17, which in turn reduces 
Results 
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cellular iron uptake rates. These posttranscriptional feedback mechanisms allow cells to 
balance cellular iron homeostasis.  
There are, however, growing numbers of reports on specialized cell types and 
tissues that at least under certain instances bypass the IRE/IRP system20-23, one 
prominent example being erythroid cells24,25. Apart from their especially high iron needs, 
they express an erythroid-specific isoform of aminolevulinic acid synthase (ALAS-E), a 
key enzyme in erythroid heme synthesis. ALAS-E is essential for erythroid 
differentiation26. Like Fer mRNAs it contains a functional IRE in its 5'-UTR (for a review, 
see Sadlon et al27). Thus iron-dependent regulation of ALAS-E should allow cells to 
coordinate the production of protoporphyrin IX with cellular iron levels. The resulting 
coregulation of TfR1, Fer subunits, and ALAS-E may be meaningful in erythroid cells 
undergoing self-renewal (ie, sustained proliferation without differentiation), but once 
induced for terminal differentiation, these cells need saturating doses of Fe2-Tf for proper 
maturation28-30. Consequently, committed erythroblasts have to maintain high expression 
of TfR1 despite increasing intracellular iron concentrations. Furthermore, synthesis of Fer 
must not be activated by incoming iron, because this would lead to counterproductive 
storage in a phase of high iron demand31. Thus, the regulation of TfR1, Fer, and ALAS-E 
expression during erythroid differentiation is difficult to reconcile mechanistically with the 
principles outlined.  
In this paper, we therefore addressed iron metabolism during terminal 
erythropoiesis of primary mouse erythroid progenitors, using a unique hematopoietic 
culture system. This, for the first time, permitted us to analyze the complexity of 
posttranscriptional regulation of IRE-containing mRNAs by iron during sustained 
proliferation versus terminal differentiation of immature erythroid progenitors under in 
vivo–like conditions. This cell model allows (1) proliferation and differentiation of 
erythroblasts derived from mouse fetal liver in serum-free medium, (2) mass cultures with 
up to 107-fold expansion of cells, yielding enough material for studies requiring a high 
amount of sample material, such as polysome gradient analyses, and (3) production of 
enucleated, fully hemoglobinized cells32,33.  
Analyses of self-renewing or differentiating mouse erythroblasts demonstrated 
that the coordinate regulation of Fer, ALAS-E, and TfR1 mRNAs via iron is abolished 
during terminal differentiation. Instead, both proteins involved in iron homeostasis (Fer 
and TfR1) are insensitive toward changes in physiologic concentrations of Fe2-Tf. 
Moreover, translation of Fer mRNA is almost entirely blocked, whereas ALAS-E mRNA is 
used to a significant extent. Artificially boosting cytosolic iron levels by addition of ferric 
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ammonium citrate (FAC), succinylacetone (SA), an inhibitor of heme biosynthesis, or 
unphysiologically high concentrations of Fe2-Tf could, however, reinduce expression of 
Fer in maturing erythrocytes. 
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5.1.3. Material and Methods 
 
Culture of primary mouse erythroblasts 
Erythroid cells were isolated and cultivated as described32,33. Briefly, cells were grown 
from fetal livers from E12.5 embryos (wild-type, MF1 background) and resuspended in 
serum-free StemPro-34 medium plus Nutrient Supplement (Invitrogen-Gibco, Carlsbad, 
CA) plus 2 U/mL human recombinant erythropoietin (Epo; 100 ng/mL), murine 
recombinant stem cell factor (SCF; 100 ng/mL), the synthetic glucocorticoid 
dexamethasone (Dex; 10–6 M), and insulin-like growth factor 1 (IGF-1; 40 ng/mL). Cell 
number and size distribution of cell populations were monitored daily in an electronic cell 
counter (CASY-1, Schärfe-System, Reutlingen, Germany). Dead or differentiating cells 
were removed by Ficoll purification.  
To induce terminal differentiation, continuously self-renewing erythroblasts were 
washed twice in PBS and seeded in StemPro-34, containing 10 U/mL Epo, insulin (4 x 
10–4 IU/mL), the Dex antagonist ZK-112993 (3 x 10–6M)34 and iron-saturated human 
transferrin (Fe2-Tf; 1 mg/mL = 12.5 µM = 25 µM Fe = physiologic levels; Sigma, St Louis, 
MO). Where indicated, heme synthesis was inhibited by 0.2 mM SA (Sigma)35. 
To induce iron starvation, cells were incubated with 50 µM of the iron chelator 
desferrioxamine (Des); iron overload was induced by adding Fe2-Tf up to 0.1 mM or FAC 
(20 µg/mL, 17% saturation = 63 µM iron) 24 hours before harvest. 
 
Cell morphology, histologic staining, and determination of hemoglobin content 
Changes in cell morphology during differentiation were monitored by phase-contrast 
microscopy. For histologic analysis, erythroblasts were cytocentrifuged36 at various 
stages of maturation onto glass slides and stained with histologic dyes and neutral 
benzidine for hemoglobin as described36. Hemoglobin content was analyzed by removing 
50-µL aliquots from the cultures and by undergoing photometric determination as 
described37. Values obtained from triplicate determinations were averaged and 
normalized to cell number and cell volume. 
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Flow cytometry 
Self-renewing or differentiating erythroblasts (1 x 106) were washed twice with PBS/2% 
fetal calf serum (FCS) and stained with fluorescently labeled antibodies against 
transferrin receptor (FITC; PharMingen, San Diego, CA; no. 01595) and Ter119 (PE; 
PharMingen, no. 09085)38. Surface marker expression was analyzed by flow cytometry 
(LSR-I; Becton Dickinson, Franklin Lakes, NJ). 
 
Northern blot analysis 
Total RNA was prepared from 2 to 4 x 107 cells using TRIzol (Invitrogen). Then, 10 µg 
total or polysomal RNA/sample was separated in denaturing 1% formaldehyde-agarose 
gels. Equal loading was controlled by ethidium bromide staining. RNA was transferred to 
nylon membranes (Gene Screen; DuPont, Wilmington, DE), and fixed by UV irradiation 
(1200 mJ; UV-Crosslinker; Stratagene, LaJolla, CA). Membranes were sequentially 
hybridized with [32P]-labeled cDNA probes generated by random-primed labeling (Prime-
it-II; Stratagene) specific for mouse FerH (0.85-kb AatII-NdeI fragment), FerL (0.3 kb, 
AatII-NdeI), ALAS-E (1.4 kb, AatII-NotI), TfR1 (0.75 kb, EcoRI-HindIII), and -globin 
mRNAs. Probes for IRP1 and IRP2 mRNA were obtained from the RZPD library of the 
German Resource Center for Genome Research (#IMAGp998J182131, Eco-HindIII; 
IRP2 #IMAGp998I191339, SacII-MluI, respectively). Signals were quantified by phospho-
imaging. 
 
Polysome gradients 
The extent of mRNA association with polysomes was determined by sucrose-gradient 
analysis39 with RNA prepared from 2 to 4 x 107 cells. After removal of nuclei and cell 
debris by centrifugation, lysates were laid onto 15% to 40% sucrose gradients and 
separated by ultracentrifugation. RNA was harvested from 18 fractions, separated on 
denaturing agarose gels, and transferred onto nylon membranes as described40. 
Distribution of 18S and 28S rRNA was visualized by staining of filters with methylene 
blue. 
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Electrophoretic mobility shift assays 
RNA-protein complexes were resolved essentially as described39,41. Briefly, for 
electrophoretic mobility shift assays (EMSAs), cytoplasmic extracts were incubated with 
[32P]-labeled transcripts produced by T7 RNA-polymerase after linearization of the 
plasmid pGEM-3Zf(+)-mouse FerH-IRE (clone42)42 with BamHI. Protein (2 µg) and 1.3 x 
106 disintegrations per minute of labeled IRE-containing in vitro transcript were incubated 
for 20 minutes at room temperature. The total amount of IRP1 was assessed by in vitro 
reduction with 2% β-mercaptoethanol (2-ME)43 prior to the binding reaction. After 
treatment with RNAse T1 and heparin, RNA-protein complexes were resolved on 6% 
non–denaturing polyacrylamide gels at 4°C. Bands corresponding to IRE/IRP complexes 
were quantified by phospho-imaging (Molecular Dynamics, Sunnyvale, CA). 
 
Western blot analysis 
Cell pellets were lysed in sample buffer as described38 and 10 to 20 µg protein was 
separated on sodium dodecyl sulfate-polyacrylamide gels. Protein transfer and loading 
were visualized by staining with acidic Ponceau-S solution. Thereafter, membranes were 
blocked 1 hour at room temperature with 1% low-fat dry milk in TBS and probed 
overnight with anti–horse spleen ferritin (Sigma; no. F-6136) or anti–rat IRP144, rat 
monoclonal anti–mouse TfR1 (BioSource, Nivelles, Belgium; no. AMS7102) or, for 
normalization, with anti-Erk1/2 (Sigma; no. 5670). After washing, filters were incubated 
with second antibody (horseradish peroxidase–coupled anti–rabbit IgG antibody 
(Jackson Laboratories, West Grove, PA; no. 111-035-008) for Fer, IRP1, Erk1/2, eIF4E, 
and anti–rat IgG (Jackson Laboratories; no. 112-035-008) for TfR1. After washing, 
immunoreactive signals were detected by enhanced chemoluminescence (Amersham, 
Buckinghamshire, United Kingdom). 
 
ALAS-E immunoprecipitation and enzyme activity 
Protein levels of ALAS-E were determined by immunoprecipitation of [35S]-methionine 
pulse-labeled cell extracts using a polyclonal antiserum developed in rabbit (a kind gift 
from M. Hentze and B. Galy, European Molecular Biology Laboratory, Heidelberg, 
Germany EMBL) and visualized by phospho-imaging. Enzyme activity was determined 
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by fluorometric high-performance liquid chromatography (HPLC) of the reaction product 
δ-aminolevulinic acid45 in cell extracts after removal of nuclei.  
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5.1.4. Results 
 
Extended self-renewal and synchronous differentiation of primary, fetal liver–
derived erythroblasts 
Most studies on iron metabolism in erythroid cells so far were done with erythroleukemic 
cell lines or reticulocytes. Murine erythroleukemia cells have provided insights into 
mechanisms controlling erythroid differentiation46 but have severe drawbacks. 
Importantly, they are unresponsive toward physiologic maturation stimuli, including Epo. 
Thus, differentiation is induced artificially by nonphysiologic agents such as dimethyl 
sulfoxide, hexamethylenebis-actamid and the like. In addition, poor hemoglobinization 
and abnormal morphologic changes during differentiation originate from patterns of gene 
expression different from those in normal erythropoiesis47. Reticulocytes represent a 
more physiologic system, but poorly represent the proliferative and early differentiation 
aspects of erythropoiesis48.  
In this study, primary mouse erythroid cells were used, which closely recapitulate 
several aspects of terminal maturation in vivo, including size decrease, full 
hemoglobinization, and enucleation33,49. These cells, from fetal livers of E12.5 mouse 
embryos, can be expanded under self-renewing conditions (sustained proliferation 
without differentiation) for 15 to 20 days before undergoing senescence (Figure 1A). 
Substitution of SCF plus Dex with insulin and the glucocorticoid antagonist ZK34 plus 
increase of erythropoietin are sufficient to induce highly synchronous terminal maturation, 
largely completed within 72 hours (Figure 1B). Noteworthy, the most substantial increase 
in hemoglobin content occurs between 24 and 48 hours after induction of differentiation 
(Figure 1D), accompanied by cell size decrease to half the original volume (Figure 1C). 
At this stage, the erythroblasts up-regulate differentiation markers like Ter119, whereas 
markers typical for immature cells disappear32. Thus, with respect to regulation of iron 
metabolism, special focus was put on this interval. This period is also characterized by 
sufficient transcriptional activity allowing interference with gene expression, whereas at 
later stages chromatin condensation (prior to enucleation) shuts down nuclear activity. 
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Translational repression of Fer mRNA and efficient utilization of ALAS-E mRNA 
in differentiating mouse erythroblasts 
Following the "standard" model of IRP/IRE-mediated translational regulation, increase in 
cellular iron uptake in hemoglobinizing cells should not only activate more efficient 
translation of ALAS-E mRNA (to ensure high levels of protoporphyrin IX synthesis) but 
also favor (futile) synthesis of iron storage proteins. 
To address this question, translation of both Fer and ALAS-E mRNAs was 
monitored by polysome gradient analysis of erythroblasts kept under proliferation or 
differentiation conditions, either iron-depleted by addition of the iron chelator Des or fully 
iron-loaded by incubation with additional Fe2-Tf (1 mg/mL). Polysome-associated mRNAs 
were fractionated from untranslated mRNPs by linear sucrose gradients (see "Materials 
and methods"). After RNA isolation and separation, blots were hybridized with probes 
specific for FerH, FerL, ALAS-E, and α-globin mRNAs. In self-renewing erythroblasts, 
translation of FerH, FerL, and ALAS-E mRNAs was still modulated by availability of iron 
(Figure 2A). Under high iron conditions, there was an increase of mRNA in polysome-
bound fractions from 2% to 9% for FerH, from 2% to 19% for FerL, and from 9% to 25% 
for ALAS-E (Figure 2B, left panels). The small percentages of polysome-bound FerL/H 
mRNA in proliferating erythroblasts even under high iron conditions are comparable to 
the earlier observations51,52. When erythroblasts differentiating for 48 hours were 
subjected to the same analysis, however, iron-induced translational activation of FerH or 
FerL (or both) was abolished (Figure 2A-B). Control α-globin mRNA was translated with 
high efficiency under both low and high iron conditions. Thus, Fer mRNA translation can 
be activated by physiologic concentrations of Fe2-Tf under self-renewal conditions but not 
in maturing erythroblasts that are accumulating hemoglobin. In contrast, ALAS-E mRNA 
translation remained regulated by iron levels after the onset of differentiation (16% 
polysome-bound mRNA under iron starvation versus 41%; Figure 2B, right panels). 
Therefore, under all conditions tested, ALAS-E mRNA was translated more efficiently 
than Fer transcripts in proliferating as well as differentiating cells. 
In maturing erythroid progenitors, efficient ALAS-E mRNA translation was 
accompanied by a massive increase in transcript levels of more than 20-fold. 
Interestingly, also transcription of FerL augmented significantly (3-fold; Figure 2E)53 but 
unlike ALAS-E mRNA, this increase was not accompanied by an increase of transcripts 
engaged to polysomes (Figure 2B), as reported earlier for differentiating murine 
erythroleukemia (MEL) cells54. 
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The data on the mRNA level were corroborated by analyses at the protein level. 
In differentiating mouse erythroblasts Fer expression stayed at low levels, irrespective of 
cell preincubation with Des or Fe2-Tf (Figure 2C), whereas ALAS-E protein synthesis 
rates as measured by immunoprecipitation indicated a 2.4-fold increase (Figure 2D). The 
low levels of ALAS-E protein synthesis in proliferating cells were in accordance with the 
much lower abundance of the corresponding mRNA (Figure 2E). Moreover, quantitation 
of the ALAS-E reaction product, δ-aminolevulinic acid by HPLC produced similar results 
(data not shown). 
 
TfR1 expression in differentiating primary mouse erythroblasts is independent of 
iron 
It is well documented that during definitive erythropoiesis uptake of iron by mouse 
erythroid cells is mediated predominantly via Fe2-Tf/TfR1 endocytosis30. Studies with 
mouse erythroid cell lines24,25 have emphasized the importance of this pathway to supply 
maturing erythroid cells with sufficient iron. After initial work with primary chicken 
erythroid progenitors24,55, here we extended these observations to primary mouse 
erythroblasts, using physiologic concentrations of Fe2-Tf as iron source and Des to 
induce iron deprivation. Whereas in self-renewing cells TfR1 mRNA levels were 
regulated by iron, erythroblasts induced to differentiate maintained high expression of 
TfR1 mRNA under both conditions (Figure 3A). Furthermore, TfR transcript levels in 
maturing cells were elevated, even in comparison to self-renewing cells supplemented 
with Des. The corresponding total cellular TfR1 protein levels followed the same pattern 
(Figure 3B). Additionally, cell-surface TfR1 expression was determined by flow 
cytometry. In the absence of iron chelator, self-renewing erythroblasts decreased the 
number of TfR1 molecules on the cell surface, whereas during differentiation, in the 
phase of high iron demand, no iron-dependent changes could be observed (Figure 3C). 
Interestingly, although terminal erythropoiesis led to a significant elevation of TfR1 mRNA 
and total protein levels, cell-surface expression was even somewhat reduced compared 
with self-renewing cells, reminiscent of the situation in chicken erythroblasts55 and 
arguing for redistribution of TfR1 toward later endosomal compartments in the cell during 
maturation56. 
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In differentiating erythroblasts, IRP1 and IRP2 are not regulated by iron 
Next we sought to address the role of IRPs during self-renewal and late stage of 
erythroid differentiation. For this, we performed EMSAs between IRP1 and IRP2 and 
radiolabeled mouse FerH-IRE RNA probes transcribed in vitro, using the IRE probe C42, 
which was shown to exhibit an equal binding affinity for IRP1 and IRP2.42  
In line with the regulation observed for FerH/L, ALAS-E, and TfR1 mRNAs, self-
renewing erythroblasts still showed an iron-dependent regulation of IRP1 mRNA-binding 
activity, even though this difference was clearly weaker compared with extracts prepared 
from control mouse embryo fibroblasts (Figure 4A). In differentiating erythroblasts, 
however, mRNA-binding activity of IRP1 declined strongly and remained totally 
indifferent toward iron sequestration. To determine the total amount of potentially 
available IRP1 mRNA-binding capacity, β-mercaptoethanol (2-ME)43,57 was added to the 
binding reaction prior to addition of labeled IRE probes. Whereas this treatment strongly 
activated binding activity in self-renewing erythroblasts as well as control cells, the level 
of activation in differentiating cells was weaker, although comparison of the differences in 
IRP1 expression revealed that total IRP1 protein and mRNA levels from self-renewing 
versus differentiating cells remained almost constant under all conditions tested (Figure 
4B-C). One reason for this apparent discrepancy (see "Discussion") lies in the technical 
principle of EMSAs. This assay for native IRE/IRP complexes using radiolabeled IRE 
transcripts detects free IRP not already stably associated with endogenous unlabeled 
IREs.58 Therefore, in committed erythroid cells, a higher proportion of IRPs may be 
associated with an increased number of IRE-bearing transcripts. 
We also assessed the regulation of IRP2 expression during terminal 
erythropoiesis by Northern and Western blot analyses. Similar to IRP1, no significant 
increase in total IRP2 mRNA or protein levels was detected during differentiation; thus 
the decline in IRP1 mRNA-binding activity is apparently not compensated by an increase 
of IRP2 expression. More importantly, whereas pretreatment with Des in self-renewing 
cells was able to increase IRP2 protein abundance (and thus mRNA-binding activity as 
measured in EMSAs; Figure 4A), no iron-dependent response was detectable in 
differentiating erythroblasts (Figure 4C). 
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Iron overload and inhibition of heme synthesis restore up-regulation of Fer 
expression in differentiating mouse erythroblasts 
Finally, we tried to gain some mechanistic insight into the question why high iron levels 
fail to induce Fer mRNA translation during normal differentiation of mouse erythroid 
progenitors. For this we used (1) FAC to test whether iron overload via this reagent would 
result in a cellular response, (2) unphysiologically high concentrations of Fe2-Tf, and (3) 
the heme synthesis inhibitor SA. All 3 types of intervention led to a substantial increase in 
the protein level of FerL and FerH (Figure 5A), arguing against an iron-independent 
mechanism specifically inhibiting Fer mRNA translation. None of these treatments, not 
even addition of high Fe2-Tf levels, resulted in significantly elevated rates of heme 
synthesis, but, as expected, was reduced by 70% on treatment with SA (Figure 5B). 
Judging by the amount of Fer synthesized, Fe2-Tf endocytosis rates may reach 
saturation at about 4 mg/mL, 4-fold higher than the in vivo serum concentration. 
Apparently the endocytosis machinery for TfR1 internalization is not the limiting factor for 
hemoglobin production but rather the synthesis capacity for heme/hemoglobin itself. At 
present we cannot distinguish between 2 alternative explanations for our results. First, 
the reagents used may directly increase the so called "labile iron pool"59,60 in the cytosol. 
This is likely to occur in the case of FAC, which might be taken up directly via non–TfR-
based pathways20-25. Second, cytoplasmic iron levels might increase secondarily after 
efflux of excess iron from mitochondria, a plausible event in response to SA and high 
Fe2-Tf treatment.  
In either case our data strongly support the view that the IRE/IRP system in 
differentiating erythroid cells is sensing a "low-iron" state despite increasing cellular iron 
levels, but remains fully functional. Furthermore, the results obtained from inhibition of 
heme synthesis support the hypothesis that the cytoplasmic iron levels sensed by IRP 
may actually be kept low during erythropoiesis by a vectorial transport of iron into 
mitochondria29,61-63, the site of iron insertion into protoporphyrin, thus bypassing the 
cytoplasmic "labile iron pool." As detailed (Figure 6), all our observations can be 
integrated into a comprehensive working model of how the flow of iron might occur during 
the phase of massive hemoglobinization.  
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5.1.5. Discussion 
 
Here we demonstrate that during terminal differentiation of primary mouse erythroid 
progenitors, Fer mRNA translation is massively impaired, whereas translation of ALAS-E 
mRNA, presumed to be regulated coordinately with Fer mRNA via the IRE/IRP system, 
proceeds unimpeded. Furthermore, maturing erythroblasts express very high levels of 
TfR1, again independent of varying iron supply or IRP activity levels. These observations 
contrast the "standard" mode for regulation of intracellular iron metabolism in most other 
cell lineages, which includes (1) up-regulation of IRP mRNA-binding activity on iron 
depletion, which in turn (2) increases Fe2-Tf import via stabilization of TfR1 mRNA and 
(3) represses iron storage via translational inhibition of Fer mRNA. Interestingly, this 
"standard" mode also applies to committed, self-renewing mouse erythroid progenitors, 
which do not yet accumulate hemoglobin and are thus independent of mechanisms to 
ensure high iron uptake. In contrast, terminal differentiation into erythrocytes uncouples 
the coordinate regulation of Fer and ALAS-E mRNA translation, and elevated expression 
of TfR1 persists despite the presence of high (physiologic) levels of Fe2-Tf. This type of 
regulation is perfectly suited to ensure maximum hemoglobin accumulation but difficult to 
reconcile mechanistically with the "standard" model. 
Previously we reported related findings for committed or differentiating chicken 
erythroid progenitors55. There, (1) TfR1 levels were very high, even under saturating 
doses of Fe2-Tf, involving transcriptional and posttranscriptional mechanisms15,25,55,64,65; 
(2) Fer mRNA translation was massively impaired and could not be modulated by iron40, 
whereas (3) ALAS-E mRNA was translated efficiently40. Nevertheless, avian 
erythroblasts differ in several aspects from those in mammals, for example, in their lack 
of enucleation. Furthermore, apparently missing expression of FerL40 and deviation in the 
hexa-loop consensus sequence (5'-CAGUGN-3' 5'-CAGCGN-3') of the ALAS-E-IRE40 
could result in differences of iron metabolism during avian versus mammalian 
erythropoiesis. 
Obviously, based on both, chicken and mouse data, the regulation model of iron 
metabolism needed extension to account for specific requirements of maturing 
erythroblasts, which have to establish exceedingly high rates of iron uptake for 
successful hemoglobinization without activating iron storage. We addressed this problem 
using primary mouse erythroblasts32,33, which expand more than 107-fold in serum-free 
media and undergo terminal differentiation in response to Epo plus insulin (Figure 1). In 
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polysome gradient analyses, we compared iron-dependent translational regulation of 
FerH, FerL, and ALAS-E mRNAs. "Low" iron conditions were simulated by addition of the 
iron chelator Des, "high" iron conditions were achieved by supplementing the medium 
with physiologic levels of Fe2-Tf (1 mg/mL). In immature, self-renewing erythroblasts, 
translation of all 3 transcripts was still coordinately regulated by the availability of iron. 
During advanced stages of erythroid maturation, however, translation of both Fer 
transcripts was almost completely blocked, irrespective of iron (Figure 2A-B). In contrast, 
the fraction of polysome-bound ALAS-E mRNA almost doubled during differentiation. 
Furthermore, there was a more than 10-fold increase in total ALAS-E mRNA (Figure 2D). 
Interestingly, the 2.5-fold difference in the amount of polysome-bound ALAS-E transcripts 
(2.4-fold in protein expression) between samples treated with or without iron chelator 
only slightly affected hemoglobin formation (15% ± 2%; not shown). This suggests that 
ALAS-E alone is not limiting for hemoglobinization under physiologic conditions (12.5 
µMFe2-Tf), in line with our observation that in ALA assays the factor of regulation by iron 
was smaller (1.6-fold ± 0.1) than on the level of ALAS-E-protein or -mRNA. These and 
related findings by others are most likely due to compensatory mechanisms66,67. A 
potential contribution of the non–IRE-containing isoform of ALAS68 is unlikely, because 
ALAS-E–/– mouse embryos have no hemoglobinized cells and die at day E11.5, at the 
onset of fetal liver erythropoiesis26 
Why then should ALAS-E mRNA expression be regulated by iron at all? 
Translational repression in self-renewing cells, together with other mechanisms, might 
help to avoid premature onset of heme synthesis. One might further assume that, 
together with high expression of TfR1 mRNA, massive transcriptional activation of the 
ALAS-E gene leads to an excess of IRE sites over available IRP molecules. Thus 
abundant de novo synthesized ALAS-E transcripts would escape this inhibitory 
interaction due to the limiting amount of "free" IRPs available. 
Reduced availability of IRPs and increase in IREs may be, however, insufficient to 
fully explain the observed uncoupling of translation efficiency between Fer and ALAS-E 
mRNAs during erythropoiesis. A second important factor in the translational activation of 
ALAS-E mRNA may be the potentially different role of IRP1 versus IRP2 in 
erythropoiesis. As recently reported, IRP2 knockout mice exhibit microcytic anemia69,70. 
Although there are discrepancies regarding the regulation of Fer and ALAS-E in erythroid 
cells from these animals, which may arise from the use of total bone marrow cells versus 
sorted erythroid progenitors, both reports describe down-regulation of TfR1 in the 
erythroid compartment. On the other hand, mice lacking IRP1 did not show an erythroid 
phenotype. Thus, in mice, IRP2 can compensate for the loss of IRP1 but not vice versa71. 
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This, however, does not rule out an important function for IRP1 during erythropoiesis 
because heme synthesis in zebrafish is strongly connected to regulation of IRP1 binding 
activity72. Moreover, the microcytic anemia observed in IRP2–/– mice is more severe in an 
IRP1+/– background, again arguing for a contribution of IRP1 to iron regulation in erythroid 
cells. These in vivo data and in vitro experiments showing a higher affinity of IRP2 for 
bulge/loop hairpins as in Fer mRNA73,74 plus high affinity of IRP2 for the multiple IREs in 
the context of TfR mRNA75 could explain the difference in IRE-mediated translational 
inhibition via IRPs in erythroid cells; IRP2 might be mainly responsible for regulation of 
TfR1, whereas IRP1 would preferentially modulate expression of ALAS-E. At present this 
scenario is speculative, especially because the existing knockout data on the roles of 
IRPs in the hematopoietic lineage are somewhat contradictory. 
The observations described in this paper would fit to the so called "kiss-and-run" 
hypothesis29,62. It suggests that during terminal erythropoiesis endosomes come into 
close vicinity/physical contact with mitochondria to directly shuttle iron into this organelle 
for heme synthesis61,63. Thus, intermediary release of iron from endosomes into the 
cytosol would be avoided, rendering the metal concentration "low" for the IRE/IRP 
system. Alternatively, and to the same consequence, increased activity of mitochondrial 
iron importers may prevent metal accumulation in the cytosol. Increased iron influx into 
mitochondria also might explain why ALAS-E but not TfR1 or Fer mRNA remains subject 
to translational control during erythroid differentiation. Excess iron not incorporated into 
heme can be used for Fe-S cluster synthesis, which on export from mitochondria will 
reduce IRP1 mRNA-binding activity. Consequently, as described, this might activate 
mainly ALAS-E mRNA translation, as detected in polysome gradients and 
immunoprecipitations. 
Building on the "kiss-and-run" hypothesis, we put our data into a working model of 
iron utilization in late-stage erythropoiesis (Figure 6). During differentiation, ALAS-E 
mRNA abundance increases. Because total IRP1 and IRP2 protein levels do not rise in 
parallel, IRP may become limiting. This might primarily affect ALAS-E mRNA due to the 
lower affinity of IRP1 for its IRE73,74, resulting in enhanced ALAS-E synthesis. The 
increase in TfR1 expression can be reconciled with potentially limited availability of IRPs 
by a decline in the activity of the endonuclease involved in TfR mRNA turnover, as in 
chicken55. At the same time, endosomes might increasingly shuttle their iron load directly 
toward mitochondria, requiring coordinated and directed vesicle flow (Figure 6A)61-63, 
most likely involving the iron transporter DMT176-78. In differentiating erythroblasts 
endosomes become increasingly acidified, favoring release of Fe from Fe2-Tf and its 
export56. Furthermore, endosomes are redistributed from the cell periphery toward the 
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deeper intracellular space, confirmed by confocal laser and electron microscopy (Lioba 
Lobmayr and Iris Killisch, unpublished data, June 2004). Thus, the cytosol may again be 
recognized as "low iron" by the IRE/IRP system, despite a massive net increase of iron 
import into the cell. Within mitochondria, iron will be efficiently incorporated in 
protoporphyrin IX by ferrochelatase to form heme, which is assembled into hemoglobin 
immediately after mitochondrial export. 
To test the idea of a "low iron" cytosol, we artificially increased the cytosolic iron 
pool. For this we either inhibited heme biosynthesis or overloaded the cells with iron 
(Figure 6B). A block of heme synthesis by SA, an inhibitor of ALA-D62, resulted in a 
significant increase in Fer protein. Most likely, this was due to an efflux of non–heme-
bound iron via the mitochondrial iron export machinery77, inducing secondary cytosolic 
iron overload (as confirmed by others26). In turn, this should reduce IRP mRNA-binding 
activity and actually increased Fer protein expression. Fer protein levels were similarly 
up-regulated on iron overload with FAC, which enters many cell types directly, bypassing 
TfR-mediated endocytosis20-23. However, TfR-independent FAC uptake has not been 
rigorously confirmed for mouse erythroid progenitors so far24,25,79. 
At present, we cannot address whether or not mitochondrial Fer80,81 may influence 
iron efflux versus storage in mitochondria. Although mitochondrial Fer has high homology 
to cytosolic Fer and is abundant in mitochondria of human patients with sideroblastic 
anemia, its role in healthy individuals is unclear81,82. 
Here we present a comprehensive analysis of key players regulating iron 
metabolism in self-renewing versus differentiating primary mouse erythroblasts. Terminal 
erythropoiesis caused a switch of regulation to a mode where the IRP/IRE system 
sensed a low-iron state despite massively increased iron uptake, intracellular transport, 
and utilization for hemoglobin synthesis. The altered iron metabolism in differentiating 
erythroblasts may have evolved to ensure maintenance of high levels of TfR1 mRNA for 
rapid uptake of large amounts of Fe2-Tf. This mode of regulation should be important to 
ensure efficient heme production by synthesizing high levels of ALAS-E without favoring 
Fer mRNA translation, thus avoiding futile iron storage during a phase of high iron 
demand, a situation known to disturb hemoglobinization31. 
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5.1.7. Figures 
Figure 1 
 
 
 
Figure 1. Extended self-renewal and synchronous differentiation of primary, fetal 
liver–derived mouse erythroblasts. (A) Cells from fetal livers of E12.5 mouse embryos 
were cultivated in serum-free StemPro (Life Technologies) medium plus NutriMix 
supplement in the presence of stem cell factor (SCF), erythropoietin (Epo; 2 U/mL), and 
the synthetic glucocorticoid dexamethasone (Dex). Proliferation kinetics of outgrowing 
erythroblasts were determined by daily measurements of aliquots in an electronic cell 
counter (CASY) and cumulative cell numbers calculated as described50. (B) Terminal 
differentiation was induced by replacing proliferation factors with insulin, the 
glucocorticoid antagonist ZK11299334 plus high levels of Epo (10 U/mL) and Fe2-Tf (1 
mg/mL = 12.5 µM). To monitor morphologic changes in maturing cells, aliquots were 
withdrawn at daily intervals, cytocentrifuged onto slides, and stained with neutral 
benzidine (to detect hemoglobin; brownish stain) and histologic dyes36. Note size 
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decrease and enucleation of mature cells (72 hours, bottom right panel). 
Photomicrographs were taken using an Axiovert 10 microscope (Zeiss, Oberkochen, 
Germany) equipped with a 63 x oil-immersion objective lens (numerical aperture 44-07-
61; Zeiss). Images are presented at original magnification, x 630. Images were captured 
with a Sony 3CCD color video camera (Sony, Tokyo, Japan) and prepared for 
publication with IP Lab Spectrum P software 3.1.1 (Signal Analytics, Vienna, VA). (C) 
Measurements of the decline in cell volume during differentiation were performed with an 
electronic multichannel cell analyzer. Appearance of 5-µm peak indicates mature cells 
with volumes close to that of peripheral blood erythrocytes. (D) Hemoglobin levels during 
differentiation were quantitated using a photometric assay previously described, and 
normalized to both cell numbers and cell volume from 50-µL aliquots in triplicate32,37; 
error bars, SD of mean, n = 4. 
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Figure 2 
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Figure 2. Translational repression of Fer mRNA and efficient utilization of ALAS-E 
mRNA in differentiating mouse erythroblasts. Self-renewing (designated 
"proliferation" in this and the following panels) or differentiating (labeled "48h diff") 
primary mouse erythroblasts were incubated with the iron chelator desferrioxamine (Des, 
50 µM) or physiologic concentrations of iron-loaded human transferrin (Tf, 12.5 µM) for 
24 hours prior to harvesting. (A) Polysome gradient analysis. Cytoplasmic extracts were 
separated in linear 15% to 40% sucrose gradients39 and the RNA isolated from 18 
fractions analyzed by Northern blotting. Fraction 1, top, fraction 18, bottom of the 
gradient. Filters were sequentially hybridized with [32P]-labeled probes specific for mouse 
FerH, FerL, ALAS-E, and (in the case of differentiating cells) α-globin mRNA as control. 
Bottom panel, loading control; methylene blue stain of total RNA. The constant molar 
ratio between 28S and 18S RNA (top and bottom band, respectively) around fraction 9 
indicates the assembly of 80S initiation complexes and marks the approximate boundary 
between the ribosome-free, untranslated, and polyribosome-bound, translated mRNA 
compartment, as schematically depicted at the bottom. (B) Quantification of polysome-
bound, translated mRNA. Bar diagrams depict the sum of the percentage of mRNA in 
fractions 9-18 as determined by PhosphoImage analysis. (C) Fer protein expression in 
proliferating and differentiating cells. The antibody used (see "Materials and methods") 
recognizes both FerH and FerL. (D) ALAS-E expression as determined by 
immunoprecipitation of cell extracts (normalized to equal number of counts per sample) 
pulse labeled for 20 minutes with [35S]-methionine; to visualize the ALAS-E band in 
proliferating cells, this signal was amplified electronically 5 times. (E) Total mRNA levels 
for ALAS-E, FerH, and FerL mRNAs. Loading and quality control, 28S rRNA stained with 
methylene blue. 
  
Results 
61 
 
Figure 3 
 
 
 
Figure 3. Transferrin receptor expression is independent of iron in differentiating 
mouse erythroblasts. Fetal liver–derived mouse erythroid progenitors pretreated as 
described in the legend to Figure 2 were analyzed for transferrin receptor (TfR1) 
expression. (A) TfR1 mRNA determined by Northern blotting (28S rRNA hybridization as 
control); (B) total TfR1 protein determined by Western blotting; Erk1/2, loading control. 
(C) TfR1 cell-surface expression was determined by flow cytometry. 
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Figure 4 
 
 
 
Figure 4. mRNA-binding activity of IRP is independent of iron in differentiating 
primary erythroblasts. (A) Determination of apparent (left panels) and total IRP mRNA-
binding activities (right panels; +2-ME43) in extracts of mouse erythroblasts (designated 
"FL," for fetal liver–derived cells), pretreated as described in Figures 2 and 3. 
Electrophoretic mobility shift assays (EMSAs) of complexes between IRP and 
radiolabeled in vitro–transcribed RNAs containing the IREs of mouse FerH mRNA (clone 
42)42 were performed as described in "Materials and methods." Control extracts, 
demonstrating the full regulatory potential of IRP, were prepared from mouse embryo 
fibroblasts (MEFs). Total IRP1 and IRP2 protein (B) and mRNA levels (C) were 
determined by Western (Erk1/2 used as loading control) and Northern blotting (28S 
rRNA signal as RNA quality and loading control), respectively. 
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Figure 5 
 
 
 
Figure 5. Iron overload and inhibition of heme synthesis restore iron-dependent 
Fer expression in differentiating mouse erythroblasts. Fer expression as determined 
by Western blotting in erythroid progenitors differentiating for 48 hours. (A) Cells were 
either incubated for 24 hours with Fe2-Tf (6.3-100 µM; highest concentration corresponds 
to 8 times the physiologic level; top left panel), or Des (50 µM), Fe2-Tf (12.5 µM), FAC 
(63 µM Fe) and SA (0.2 µM; inhibition of heme synthesis) (top right panel). FAC probably 
can enter the cells directly, bypassing Tf/TfR-mediated endocytosis and the assumed 
vectorial iron transport from endosomes into mitochondria, and may thus lead to direct 
cytosolic iron overload ERK1/2 (bottom panels), loading control; membranes restained 
with corresponding antibody. (B) Hemoglobin synthesis in the cells described in panel A. 
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Figure 6 
 
 
Figure 6. Working model for the regulation of iron metabolism in differentiating 
primary erythroblasts. (A) The model shown in this scheme is essentially based on the 
"kiss-and-run" hypothesis62 of vectorial iron transport toward mitochondria. It depicts the 
distribution of iron (cytosolic versus mitochondrial) in differentiating erythroid cells as well 
as how the expression levels of TfR1, Fer, and ALAS-E are regulated via IRP. Thick and 
thin black arrows symbolize high and low rates of iron flow, respectively; open white 
arrows depict heme synthesis; lettering size for hemoglobin, TfR1, Fer, ALAS-E and "Fe" 
(iron-loaded heme) indicates the expression level of the corresponding protein or 
compound. (B) Predicted and in part experimentally verified consequences of (1) 
perturbation of mitochondrial iron uptake/flow by adding inhibitors of heme biosynthesis 
like succinylacetone (SA; upper panel) or (2) of direct cytoplasmic iron overload with low-
molecular-weight iron salts (ie, addition of ferric ammonium citrate, FAC; lower panel).  
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5.2.1. Abstract 
 
Differentiating erythroid cells shuttle iron with very high efficiency towards mitochondria 
for the formation of heme. Recently we have demonstrated that primary erythroid cells 
satisfy their exceptionally high requirements for iron during terminal differentiation by 
switching to a mode where the post-transcriptional, iron-dependent regulatory system, 
based on iron responsive proteins (IRP1 and IRP2) and iron responsive elements (IREs), 
seems to sense low iron levels within cells. This occurs despite a massive net increase 
of iron import into cells1.  
To examine the hypothesis that erythroid cells have low non-heme iron levels in 
their cytosol, we experimentally increased the cytosolic iron pool by either inhibiting 
heme biosynthesis or overloading cells with iron. Both treatments resulted in a clear 
increase in ferritin levels. Strikingly, increases in ferritin expression upon perturbation of 
cellular iron homeostasis strongly correlated with the loss of IRE-binding activity of IRP2 
but not IRP1. This suggests that IRP2 is the major regulator of ferritin expression in 
erythroid cells. To further elaborate on this observation, we cultured primary 
erythroblasts derived from IRP1-/- and IRP2-/- mice. In agreement with the published 
phenotype of microcytic hypochromic anemia, only erythroblasts lacking IRP2 exhibited 
a reduction in hemoglobinization and showed a significant increase in ferritin expression. 
Together with the observation that surface expression of transferrin receptor (TfR1) was 
reduced in IRP2-/- erythroblasts during self renewal but not during terminal 
differentiation, our results suggest that not only down-regulation of TfR1, but also up-
regulation of ferritin may be a major factor causing the anemic phenotype observed in 
IRP2-/- mice. 
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5.2.2. Introduction 
 
The major function of mature red blood cells is to supply oxygen to all body tissues using 
hemoglobin as a docking molecule and to remove carbon dioxide in order to deliver it to 
the lungs. To satisfy this requirement, each erythrocyte is packed with hemoglobin 
molecules. Therefore, terminally differentiating erythroid cells focus their metabolic 
efforts on the synthesis of globin and heme. Heme biosynthesis is a very efficient 
process which involves eight enzymes. The first step occurs in mitochondria and 
involves the condensation of succinyl CoA and glycine to form 5-aminolevulinic acid 
(ALA), catalyzed by ALA synthase (ALAS). The next four steps take place in the cytosol 
and are initiated by the ALA dehydratase (ALAD). The final three steps of the 
biosynthetic pathway, including the insertion of ferrous iron into protoporphyrin IX (PP IX) 
by the last enzyme of the pathway, ferrochelatase, occur again in mitochondria.   
The need for iron as a substrate for heme biosynthesis makes differentiating 
erythroid cells the major consumers of circulating iron. This plasma iron is bound to 
transferrin (Tf) which binds to the TfR1 on the cell surface. The binding is followed by 
internalization of the Tf/TfR1 complex via receptor mediated endocytosis. Endosomal 
acidification is necessary for the release of iron from the Tf-TfR1 complex2,3. Thereafter 
Fe is reduced by the ferrireductase Steap34 and transported across the vesicular 
membrane by the divalent transporter DMT15,6. Finally, iron is delivered to its place of 
utilization. Excess Fe is trapped in the iron storage protein ferritin. This sequestration 
prevents the formation of cell damaging radicals by free iron.  
Coordinated control between iron uptake and storage is mainly achieved by the 
post-transcriptional regulation of ferritin and TfR1 synthesis. Under low cellular iron 
concentrations the iron regulatory protein (IRP) 1 and IRP2 can independently bind to 
specific RNA motifs called iron responsive elements (IREs; reviewed by Pantopoulos K7). 
One type of these stem loop structures is localized in the 5’ untranslated region (UTR) of 
both transcripts of the ferritin subunits and multiple copies are found in the 3’ UTR of the 
TfR1 mRNA. Binding of IRPs to IREs leads to stabilization of TfR1 mRNA and 
consequently, to increased expression of the protein involved in iron uptake8-10. 
However, IRP/IRE complex formation in the 5’ UTR of ferritin mRNA inhibits initiation of 
translation and prevents sequestration of iron into storage compartments11,12. The 
opposite occurs if cellular iron levels are high. Release of IRPs from IREs destabilizes 
TfR1 mRNA and allows for efficient synthesis of ferritin protein. Paradoxically, this would 
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be also the situation in terminally differentiating red blood cells which show a dramatic 
increase in the uptake of cellular iron needed for hemoglobinization. Therefore, 
according to the classical IRP/IRE sensing system, this should result not only in a down-
regulation of TfR1, but also in an increase in ferritin protein expression. Hence, if this 
system operated in terminally differentiating RBCs iron would be diverted to iron storage 
instead of towards heme synthesis. In fact it has been shown that overexpression of 
ferritin H in a mouse erythroleukemic cell line leads to reduced hemoglobinization when 
these cells were induced to differentiate13. 
Recently we showed that during late stages of erythroid differentiation the 
regulation of key proteins in cellular iron metabolism do not correlate to cellular iron 
levels and are not coordinately regulated by the IRP/IRE system1. The view was initially 
that IRP1 and IRP2 may be functionally redundant; however IRP2 knock out (KO) 
animals exhibit a microcytic anemia14,15, whereas IRP1 ko animals are similar to wild type 
(WT) animals16. This difference in the RBC parameter seems to be mainly due to a 
decreased expression of TfR1 on the cell surface of erythroid progenitors in the IRP2 
knock out (KO) animals14,15, suggesting that IRP2 has a dominant role over IRP1 in 
cellular iron metabolism of erythroid cells. 
Using a primary erythroid cell system17,18 we show that during differentiation 
efficient formation of heme keeps the cytosol in an iron-deprived state and consequently 
ferritin protein levels low. This translational repression is primarily achieved by IRP2. 
Furthermore we demonstrate that erythroid progenitors derived from IRP2 KO animals 
have low TfR1 expression only in the undifferentiated state but reach levels equal to WT 
cells during the end stage of terminal differentiation. In contrast, ferritin expression stays 
up-regulated during the entire differentiation process suggesting that sequestration of 
incoming iron by ferritin in these cells might be the major cause of the observed 
microcytic anemia.  
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5.2.3. Material and Methods 
 
Culture of primary mouse erythroblasts 
Erythroid cells were isolated and cultivated as described17,18. Briefly, cells were grown 
from fetal livers collected from E12.5 embryos (WT, MF1 background) and re-suspended 
in serum-free StemPro-34™ medium plus Nutrient Supplement (Invitrogen-GIBCO, 
Carlsbad, CA) plus 2U/mL human recombinant erythropoietin (Epo; 100ng/mL), murine 
recombinant stem cell factor 100ng/mL (SCF), synthetic glucocorticoid dexamethasone 
(Dex; 10-6M) and insulin-like growth factor 1 (IGF-1; 40ng/mL). Cell number and size 
distribution of cell populations were monitored daily in an electronic cell counter (CASY-
1, Schärfe-System, Reutlingen, Germany). Dead or differentiating cells were removed by 
Ficoll purification. 
To induce terminal differentiation, continuously self-renewing erythroblasts were 
washed twice in PBS and seeded in StemPro-34TM, containing 10U/mL Epo, insulin (Ins, 
4x10-4IE/mL), Dex antagonist ZK-112993 (3x10-6M)19 and iron-saturated human 
transferrin (Fe2-Tf; 1mg/mL=12.5µM=25µM Fe=physiological levels; Sigma, St. Louis, 
MO). Where indicated, heme synthesis was inhibited by 0.2mM succinylacetone (SA; 
Sigma)20. 
To induce iron starvation, cells were incubated with 50µM of the iron chelator 
desferrioxamine (Des); iron overload was induced by adding ferric ammonium citrate 
(FAC; 20µg/mL, 17% saturation=63µM iron) 24h before harvest. 
 
Cell morphology, histological staining, and determination of hemoglobin content 
Changes in cell morphology during differentiation were monitored by phase-contrast 
microscopy. For histological analysis, erythroblasts were cytocentrifuged at various 
stages of maturation onto glass slides and stained with histological dyes and neutral 
benzidine for hemoglobin as described21. Hemoglobin content was determined 
photometrically from 50µl aliquots from the cultures as described22. Values obtained from 
triplicate determinations were averaged and normalized to cell number and cell volume. 
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Flow cytometry 
1x106 self-renewing or differentiating erythroblasts were washed twice with PBS/2% fetal 
calf serum (FCS) and stained with fluorescently-labeled antibodies against transferrin 
receptor (FITC, PharMingen, San Diego, CA, #01595). Surface marker expression was 
analyzed by flow cytometry (LSR-I, Becton Dickinson, Franklin Lakes, NJ) and 
processed with CellQuest Pro Software version 1.3. 
 
Electrophoretic mobility shift assays 
RNA-protein complexes were resolved essentially as described23,24. Briefly, for 
electrophoretic mobility shift assays (EMSAs), cytoplasmic extracts were incubated with 
[32P]-labeled transcripts produced by T7 RNA-polymerase following linearization of the 
plasmid pGEM-3Zf(+)-chicken FerH-IRE with BamHI. 20µg of protein and 1.3x106 dpm of 
labeled IRE-containing in vitro transcript were incubated for 20min room temperature. 
The total amount of IRP1 was assessed by in vitro reduction with 2% beta-
mercaptoethanol (2-ME)25 prior to the binding reaction. After treatment with RNAse T1 
and heparin, RNA-protein complexes were resolved on 6% non-denaturing 
polyacrylamide gels at 4°C. Bands corresponding to IRE/IRP complexes were quantified 
by phospho-imaging (Molecular Dynamics, Sunnyvale, CA). 
 
Western blot analysis 
Cell pellets were lysed in sample buffer as described26 and 10-20µg of protein separated 
on SDS-polyacrylamide gels. Protein transfer and loading were visualized by staining 
with acidic Ponceau-S solution. Thereafter, membranes were blocked one hour at room 
temperature with 1% low-fat dry milk in TBS and probed overnight with anti-horse spleen 
ferritin (Sigma, #F-6136) or, for normalization, with anti-Erk1/2 (Sigma, #5670) or anti-
eIF4E (Cell Signaling). After washing, filters were incubated with second antibody 
(horseradish peroxidase coupled alpha-rabbit IgG antibody (Jackson Labs., West Grove, 
PA, #111-035-008). After washing, immuno-reactive signals were detected by enhanced 
chemo-luminescence (Amersham, Buckinghamshire, England). 
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5.2.4. Results 
 
Ferritin expression is iron-dependent in terminally differentiating primary erythroid 
cells 
Although cellular iron levels increase dramatically in differentiating erythroid cells, 
translation of ferritin remains in a repressed state1. To test whether ferritin expression is 
still responsive to iron we employed ferric ammonium citrate (FAC) as an iron source. 
Both undifferentiated and differentiating (48h) erythroblasts were incubated for 24h with 
FAC. Western blot analysis shows that increasing concentrations of FAC correlate with 
increasing expression of ferritin (Figure 1). Thus, these data argue against the possibility 
that an iron independent mechanism specifically inhibits ferritin mRNA synthesis during 
terminal differentiation. 
 
Inhibition of heme synthesis activates expression of ferritin in differentiating 
erythroblasts 
The switch to a repressed state of ferritin levels despite a net increase in cellular iron 
correlates with a rise in hemoglobinization (data not shown). In order to test for a link 
between heme biosynthesis and regulation of ferritin expression, we blocked heme 
biosynthesis at two different stages. First, we used succinylacetone (SA) to inhibit ALAD, 
the second enzyme of the heme biosynthesis pathway20. As shown in Figure 2A, 
inhibition of ALAD by 0.2mM SA for 24h clearly reduced heme biosynthesis and led to an 
equivalent increase in ferritin protein expression (Figure 2B). This indicates that 
functional heme biosynthesis is necessary to keep ferritin expression at low levels. 
  
Ferritin expression negatively correlates with heme synthesis 
Secondly, we used isonicotinic hydrazide (INH) to inhibit aminolevulinic acid synthase 
(ALAS-E), the first enzyme of the heme synthesis pathway. As shown in Figure 3A 
inhibition of heme production by INH was comparable to the inhibitory effect of SA on 
48h differentiated erythroblasts. INH causes a similar block of heme biosynthesis and a 
marked increase in ferritin protein expression (Figure 3B). The block of heme 
biosynthesis by INH could be partially restored by addition of ALA. As shown in Figure 3, 
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0.5mM and 1mM ALA can re-establish about 30% and 60% of heme biosynthesis, 
respectively. Strikingly, with augmented restoration of heme formation we obtain a 
parallel decrease in ferritin protein levels as shown by western blot analysis. Thus, this 
data supports the view of an inverse correlation between heme biosynthesis and ferritin 
protein expression.  
  
Cytosolic iron overload by FAC or inhibition of heme synthesis is sensed by IRP2 
but not IRP1 
To determine if the incubation with FAC or the inhibition of heme synthesis that were 
both followed by an upregulation of ferritin changed the binding activities of IRPs we 
performed electro mobility shift assay (EMSA) using a radio-labeled IRE probe and 
looked at complex formation between this probe and IRP1 and IRP2. As previously 
shown, incubation of both undifferentiated and differentiated erythroid cells with FAC 
increased the expression of ferritin in those cells (Figure 4A, left panel). Again the same 
is true upon treatment of 48h differentiated erythroblasts by SA only or in combination 
with FAC (Figure 4, right panel). Following analysis of IRP1 and IRP2 binding activity, 
however, only the formation of IRP2/IRE complexes was reduced, whereas the binding 
activity of IRP1 is unaffected (Figure 4B). Because decrease in binding activity of IRP2 
nicely correlates with the increase in ferritin expression, we conclude that changes in the 
cellular iron balance by administration of FAC or inhibition of heme synthesis by SA are 
mainly sensed by IRP2 and not by IRP1. Therefore we postulate that translational 
regulation of ferritin in these cells is primarily achieved by IRP2 and not by IRP1. 
 
IRP2 is the major regulator of iron-dependent expression of ferritin 
To further investigate the possibility that the translation of ferritin is mainly regulated by 
IRP2 and not IRP1 in erythroid cells, we used erythroid progenitors derived from fetal 
livers of mice deficient in IRP1 or IRP215. We kept the isolated erythroblasts under either 
undifferentiated conditions or induced them to differentiate for 48h17. Expression of TfR1 
was determined by fluorescence-activated cell sorting analysis (FACS). In agreement 
with in vivo data14,15 only undifferentiated erythroblasts deficient in IRP2 but not those 
deficient in IRP1 showed a reduced expression of TfR1 on their cell surface (Figure 5C). 
Moreover only erythroid cells derived from IRP2 KO animals showed a decrease in 
hemoglobin accumulation after 48h of differentiation (Figure 5A), in agreement with the 
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microcytic anemia observed only in these animals14,15. Western blot analysis of ferritin 
expression in undifferentiated and 48h differentiated erythroblasts demonstrated that 
ferritin protein was strongly elevated in IRP2-/- cells, but not in IRP1-/- cells as compared 
to the WT counterpart (Figure 5B). These results underline the notion that IRP2 is the 
major translational regulator of ferritin expression in erythroid cells. 
Moreover, the TfR1 expression on the cell surface was compared between 
undifferentiated erythroblast derived from KO and WT animals and their differentiated 
counterparts (Figure 5C). We could not detect any significant difference in the cell 
surface expression of TfR1 during the late stage of erythroid differentiation between all 
three genotypes (Figure 5C, right panel). Hence TfR1 is downregulated in IRP2 deficient 
erythroblasts at a stage of low hemoglobinization, whereas ferritin expression is 
upregulated throughout the whole terminal differentiation process. This suggests that the 
microcytic anemia observed in IRP2 KO animals might be less a result from 
downregulation of TfR1 during early stages of terminal erythropoiesis but primarily a 
consequence of up-regulated ferritin expression during the phase of high 
hemoglobinization. 
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5.2.5. Discussion 
 
Erythroid cells are the major consumers of iron in the human body. Differentiating 
erythroid cells shuttle the metal with very high efficiency towards mitochondria in order to 
use it for the formation of heme27. To satisfy their high iron needs, developing red blood 
cells (RBC) have to sustain high expression of TfR1 despite increasing cellular iron 
concentration. Moreover, synthesis of ferritin must not be activated by incoming iron, 
since this would represent a counterproductive storage during the phase of high iron 
demand. Recently we have demonstrated that during terminal differentiation primary 
erythroid cells maintain high TfR1 expression and low ferritin expression despite a 
massive net increase of iron import into the cell1. 
We have hypothesized that erythroid cells have low non-heme iron levels in their 
cytosol and show in this report that both block of heme synthesis by either SA or INH or 
administration of FAC, resulted in a clear increase in ferritin levels. Moreover, the effect 
of INH, the inhibitor of ALAS2, could be reversed by the addition of ALA. 
The positive correlation between increasing concentrations of FAC treatment and 
the increased expression of ferritin protein demonstrates that ferritin expression is still 
responsive to iron in differentiating erythroblasts (Figure 1). This eliminates the possibility 
of an iron-independent inhibition of the translational regulation of ferritin. Similarly the 
inhibition of heme synthesis increases the ferritin expression, however it remains to be 
elucidated how this treatments increase the regulatory iron pool. Basically, there are two 
possibilities upon treatment with FAC or inhibitors of heme synthesis: (I) once iron is 
released from endosomes it accumulates in the cytosol and this regulatory iron pool 
inactivates binding activity of IRP27; (II) iron is shuttled directly into mitochondria28 and is 
then released from this organelle when the iron availability exceeds the iron demand and 
so increases the regulatory iron pool in the cytosol. The data presented here cannot 
answer this question and we are currently trying to address these issues. 
Although it is unclear how the regulatory iron pool forms upon treatment with FAC 
or inhibitors of heme synthesis, both treatments lead to a decreased binding activity of 
IRP2, but not IRP1. Therefore we suggest that expression of ferritin is mainly regulated 
by IRP2 in undifferentiated and differentiating erythroid cells. 
This correlates with recent data using an siRNA approach showing that 
knockdown of IRP1 did not affect ferritin H expression, whereas knockdown of IRP2 
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caused an increase in ferritin expression29. This seems to be in contrast to in vitro 
translation assays demonstrating that IRP2 inhibited ferritin mRNA translation with a 
molar efficiency equal to that of IRP1 in vitro30. But additional cellular factors might tune 
the binding activity of the two IRPs differently in vivo in a tissue specific manner31. The 
view of IRP2 as a more potent regulator of the IRE than IRP1 is consistent with results 
obtained in knockout mice: IRP1 knockout mice display normal iron metabolism in most 
tissues, whereas IRP2 knockout mice show high ferritin and low TfR1 levels in multiple 
tissues16. A tissue specific effect of IRP2 deletion was shown for the erythroid 
compartment localized to the bone marrow. Only mice deficient for IRP2 but not IRP1 
developed hypochromic microcytic anemia14,15. Results of this two independent groups 
have suggested that microcytic anemia in IRP2 deficient mice is caused by deficiency of 
heme synthesis due to a decreased iron uptake which results from a significant decrease 
in TfR1 expression on erythroid precursor cells. In agreement with these data we show 
that indeed proerythroblasts have a decreased TfR1 expression on the cell surface. 
However, this difference in expression vanished at the late stage of terminal 
differentiation, i.e. at a stage of highly efficient hemoglobinization. This suggests that iron 
uptake by erythroblasts from IRP2 KO mice may not be limited during this period. On the 
other hand, expression of ferritin is still high in IRP2 deficient erythroblasts at the late 
stage of differentiation, likely sequestering the iron into storage and thus impairing heme 
synthesis. 
We conclude that the major factor responsible for hypochromic anemia in IRP2 
KO mice is the hyper-expression of ferritin which diverts iron away from mitochondrial 
heme synthesis. 
Erythroid cells express a specific erythroid form of the aminolevulinic acid 
synthase, ALAS2. In contrast to the housekeeping form, regulation of ALAS2 is 
independent of heme32. Furthermore it includes a functional IRE in its 5’-UTR. Although 
this constellation would suggest a regulation similar to that of ferritin by the IRE/IRP 
system, several studies have shown that ferritin mRNA is more potently regulated than 
ALAS2 mRNAs1,34. Furthermore, this could be potentially achieved by different roles of 
IRP1 and IRP2 in the translational regulation of ferritin and ALAS2. At present this 
scenario is speculative, especially since the existing knock out data on the roles of IRPs 
in mice and other animal models are somewhat contradictory. In fact studies in zebrafish 
have suggested that translation of ALAS2 mRNA is regulated by IRP1 and not IRP233. 
However, analysis of ALAS2 expression in IRP1 and IRP2 KO mice support IRP2 to be 
the major regulator of ALAS214. Latter observation would imply that differences in the 
translational regulation of ferritin and ALAS2 are due to differences in the structure of 
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their IRE leading to different binding affinities for IRP2. On the other hand Galy et al. do 
not observe any differences in the expression of ALAS2 between WT and KO animals. 
Therefore future studies on the expression of ALAS2 using erythroid cells derived from 
IRP1 and IRP2 KO animals should help to clarify these discrepancies. 
Although in this report we mainly focused on the expression of ferritin, one very 
interesting observation was the normalization of the TfR1 expression at the late stage of 
differentiation in the IRP2 KO cells. This suggests that at this point of erythropoiesis TfR1 
expression is regulated mainly at the level of transcription but not translation. Moreover it 
weakens the hypothesis that the microcytic anemia developed in the IRP2 KO animals is 
a consequence of decreased cellular iron uptake by erythroid cells. 
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5.2.6. Figures 
Figure 1 
 
 
Figure 1. Ferric ammonium citrate (FAC) activates ferritin expression in 
undifferentiated and differentiated erythroblasts.  
Undifferentiated (designated “undiff” in this and the following panels) or cells 
differentiating (labeled “48h diff” in this and following panels) primary mouse 
erythroblasts were incubated with increasing concentrations of FAC for 24 hours prior to 
harvesting. Bar diagrams depict the quantification by Li-Cor’s Odyssey infrared imaging 
system of the respective ferritin signals below obtained by western blot analysis.  
Results 
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Figure 2 
 
 
 
Figure 2. Inhibition of heme biosynthesis activates ferritin expression in 
differentiating mouse erythroblasts.  
Differentiating mouse erythroblasts were incubated for 24 hours with either des (50µM) 
or FAC (63µM Fe) in contrast to untreated control cells (ctrl), with or without additional 
SA treatment (0.2mM; inhibition of heme synthesis). (A) Heme assay of the described 
cells. (B) Ferritin expression was determined by western blotting; Erk1/2 (lower panels) 
was used as loading control; membranes re-stained with corresponding antibody.  
  
 86 
 
Figure 3 
 
Figure 3. Expression of ferritin correlates positively with heme biosynthesis  
(A) Heme biosynthesis in 48h differentiating erythroblasts was inhibited by incubation 
with 4mM or 8mM of INH for 24h prior to harvesting. Where indicated, cells were 
additionally treated with increasing concentrations of ALA to partially restore heme 
biosynthesis (upper panel). The heme assay was performed as described under 
“materials and methods”. (B) Ferritin protein expression was determined by western blot 
analysis and quantified by Li-Cor’s Odyssey infrared imaging system (bar diagrams); 
eIF4E (lowest panel) was used as loading control.  
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Figure 4 
 
 
Figure 4. Binding activity of IRP2 but not IRP1 is decreased upon treatment 
with FAC or SA 
The cell extracts of undifferentiated and 48h differentiating erythroblasts were used to 
determine ferritin expression and IRP binding activity. The cells were treated with FAC 
and/or SA as indicated (A) Western blot analysis of ferritin protein expression, eIF4E was 
used as loading control. (B) Aliquots of the cell extracts used for western blot were used 
for a band shift assay in order to determine the binding activity of IRP1 and IRP2. The 
total abundance of free IRP1 was monitored by the activation of non-binding IRP1 
molecules by reduction with 2-mercaptoethanol (2-ME).   
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Figure 5 
 
 
Figure 5. Analysis of hemoglobin levels, ferritin expression and TfR1 
expression in erythroid cells derived from IRP KO and WT animals 
Erythroblasts were isolated from fetal liver of KO and wt mice and either kept in an 
undifferentiated state or induced to differentiate for 48h. (A) Hemoglobin levels in 
undifferentiated and differentiating erythroid cells isolated from wt, IRP1-/- and/or IRP2-/- 
animals. (B) Ferritin protein expression was determined by western blot analysis (C) 
TfR1 expression was determined by FACS analysis.   
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5.3.1. Abstract 
 
The availability of oxygen regulates the production of erythropoietin (epo) and thus 
determines the amount of newly generated erythrocytes. Furthermore, it has been shown 
that oxygen directly influences hematopoiesis and additionally modulates iron 
metabolism, which is essential during the synthesis of heme. Hence, the adjustment of 
the oxygen concentration during the in vitro cultivation of erythroblasts is of special 
importance. 
Using a murine erythroid in vitro model, we show that low oxygen levels or the 
addition of the HIF-α activator dimethyloxalylglycine interfered with heme synthesis and 
cell-size decrease and promoted prolonged proliferation of immature erythroblasts. 
Moreover, limited oxygen supply obstructed terminal erythroid differentiation despite high 
epo levels. Our data suggest that the oxygen gradient in erythrocyte-forming 
compartments is able to directly influence the progression of erythropoiesis and that 
hypoxic oxygen levels interfere with terminal erythroid differentiation via stabilization of 
HIF-α. Furthermore, parameters like cell density and metabolic activity contribute to the 
effective oxygen concentration in the microenvironment of cultivated erythroblasts. 
Therefore, in vitro oxygen levels have to be individually adjusted to the specific needs of 
different cell types and culture conditions in order to prevent artificial effects. 
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5.3.2. Introduction 
 
Oxygen is an important factor in hematopoiesis as well as in the regulation of iron 
metabolism. Several publications have shown that hypoxia is able to directly regulate the 
cycle/quiescence balance of hematopoietic stem cells and the differentiation of 
progenitor cells1-4. Furthermore, the activity of the RNA-binding iron regulatory proteins 
IRP1 and IRP2 that post-transcriptionally regulate the expression of several proteins 
involved in iron uptake, storage and utilization is not only dependent on the availability of 
iron but also of oxygen5-7. During erythropoiesis these two regulatory functions of oxygen 
are of special importance. It has been shown that oxygen directly affects erythropoiesis 
but the underlying mechanisms are not well understood 8. In addition, reduction of 
systemic oxygen availability is responsible for the increased production of erythropoietin 
(epo) in the kidney, which is the main signal that promotes the production of mature 
erythrocytes in the hematopoietic tissues9,10. Furthermore, the influence of oxygen on the 
regulation of the IRE/IRP system is of special importance during erythropoiesis, since 
heme synthesis is dependent on the availability of iron. 
Several of these aspects are analyzed in vitro using tissue culture incubators that 
use atmospheric oxygen supply. Since the oxygen levels in vivo are generally lower than 
the atmospheric concentration of 21%, the oxygen concentration has to be adjusted to 
physiological levels in vitro, when oxygen dependent mechanisms are analyzed. 
Although this sounds trivial, there are two major aspects that make this adjustment less 
straightforward: First, the oxygen concentration is not equally distributed in the body but 
varies in the range of 14% in arterial blood to virtually 0% in ischemic tissues11. The 
adjustment of the oxygen supply in vitro should therefore correspond to the correct in 
vivo concentration of the specific area of the tissue where the cultivated cell type would 
normally be found. Furthermore, in the special case of hematopoiesis the developing 
cells are confronted with increasing oxygen concentrations during maturation, thereby 
literally travelling throw increasingly oxygenated tissue12. This variation of the oxygen 
concentration would therefore also be necessary during in vitro cultivation of 
differentiating hematopoietic cells. 
The second point that makes the adjustment of the oxygen supply comparable to 
the in vivo situation more complicated is that the modification of the oxygen 
concentration to a defined value within a tissue culture incubator does not necessarily 
mean that the cultured cells are actually facing exactly this oxygen concentration. In fact, 
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the oxygen supply rate in tissue culture is limited by the diffusion velocity of oxygen 
through the cultivation medium13,14. When the cultivated cells consume more oxygen 
than can be transferred through the medium the effective oxygen concentration becomes 
lower than the supplied concentration of the incubator. Therefore, additional parameters, 
like cell density, metabolic activity and diffusion distance also contribute to the oxygen 
supply of the cells and can further reduce the oxygen concentration in their direct 
environment15. 
We are interested in the process of erythropoiesis in general and use a murine 
primary cell culture system to study different aspects of this process including iron 
metabolism. Therefore, the influence of oxygen on this in vitro system is of special 
importance for our work. It has already been shown that the applied oxygen 
concentration of tissue culture incubators is able to modulate the process of erythroid 
differentiation in vitro8. Just recently, it has further been shown that that 
dimethyloxalylglycine (DMOG), an activator of hypoxia inducible factor-1α (HIF-1α) has a 
direct epo independent promoting influence on the proliferative capacity of the early 
erythroid progenitor BFU-E (burst-forming unit-erythroid)16. In the work presented here 
we used a murine primary cell culture system in order to further investigate the interplay 
between culture conditions, oxygen and the maturation of erythroblasts17 . We could 
show that reduced oxygen levels (3%) in contrast to near-atmospheric oxygen levels 
(20%) can promote and extend self renewal of immature erythroblasts in vitro. 
Furthermore, the same reduced oxygen levels interfered with heme synthesis, 
enucleation and proliferation even in combination with factors promoting terminal 
erythroid differentiation. Nevertheless, we could eliminate the inhibitory effect of reduced 
oxygen levels by variation of cell density and diffusion distance, demonstrating their large 
impact on the effective oxygen supply of cultivated cells. In fact, we could show that the 
conventional culture conditions reduced the oxygen concentration in the direct 
environment of the cells compared to the oxygen concentration provided by the 
incubator. This demonstrates the huge impact of different tissue culture parameters that 
need to be evaluated in order to retrieve reproducible results especially if in vivo like 
conditions need to be established.  
In addition we could show that the oxygen concentration is a potent direct 
regulator of erythroid differentiation and this regulation is mediated by the activity of 2-
oxoglutarate-dependent oxygenases. Finally, this study shows that hypoxia is able to 
directly promote the generation of erythrocytes by keeping erythroblasts in an immature 
state longer than during normal oxygen supply and at the same time allowing terminal 
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differentiation of more mature erythroblasts in more oxygenated areas of the 
hematopoietic tissue. Hence, hypoxia is able to directly promote erythropoiesis additional 
to the indirect regulation via epo expression in the kidney. 
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5.3.3. Material and Methods 
 
Culture of primary mouse erythroblasts 
Erythroid cells were isolated and cultivated as described17. Briefly, cells were grown from 
fetal livers collected from E12.5 embryos (WT, C57BL/6 background) and re-suspended 
in serum-free StemPro-34™ medium plus Nutrient Supplement (Invitrogen) 
supplemented with human recombinant erythropoietin (Epo; 2 U/mL; Erypo, Janssen-
Cilag), murine recombinant stem cell factor (SCF; 100 ng/mL; R&S Systems), synthetic 
glucocorticoid dexamethasone (Dex; 10-6 M, Sigma-Aldrich) and insulin-like growth factor 
1 (IGF-1; 40 ng/mL; Promega). Cell number and size distribution of cell populations were 
monitored daily in an electronic cell counter (CASY-1, Schärfe-System). Dead or 
differentiating cells were removed by Ficoll purification. Cumulative cell numbers were 
calculated as described18 
To induce terminal differentiation, continuously self-renewing erythroblasts were 
washed twice in PBS and seeded in StemPro-34TM, containing 10 U/mL Epo 10 U/ml) 
insulin (4x10-4 IE/mL; Actrapid HM), Dex antagonist ZK-112993 (3x10-6 M)19 and iron-
saturated human transferrin (1 mg/mL=25 µM Fe; Sigma-Aldrich). 
All cells were cultivated in an incubator supplied with 5% CO2 or an incubator 
supplied with 5% CO2 and N2 (Kendro). The oxygen concentration in the latter was 
adjusted to 3%. In order to inhibit 2-oxoglutarate–dependent dioxygenases, cells were 
incubated with 500 µM dimethyloxalylglycine (DMOG; Cayman Chemical). 
 
Cell morphology, histological staining, and determination of hemoglobin content 
Changes in cell morphology during differentiation were monitored by phase-contrast 
microscopy. For histological analysis, erythroblasts were cytocentrifuged at various 
stages of maturation onto glass slides and stained with histological dyes and neutral 
benzidine for hemoglobin as described20. Photomicrographs were taken using an 
Axiovert 10 microscope (Zeiss) equipped with a 20x lens and a 63x oil-immersion lens, a 
Zeiss AxioCam MRc5, and Axiovision LE software. Images are presented at x200 and 
x630 magnification. 
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Hemoglobin content was determined photometrically from 50 µl aliquots from the 
cultures as described21. Values obtained from triplicate determinations were averaged 
and normalized to cell number and cell volume. 
 
Flow cytometry 
1x106 self-renewing or differentiating erythroblasts were washed twice with PBS/2% fetal 
calf serum (FCS) and stained with fluorescently-labeled antibodies (all from BD 
Biosciences) against transferrin receptor (biotinylated; APC-streptavidin for detection), c-
Kit (FITC-conjugated) and Ter119 (PE-conjugated). Surface marker expression was 
analyzed by flow cytometry (FACS Calibur, BD Biosciences) and processed with FlowJo 
Software (Tree Star). 
 
Electrophoretic mobility shift assays 
RNA-protein complexes were resolved essentially as described22. Briefly, for 
electrophoretic mobility shift assays (EMSAs), cytoplasmic extracts were incubated with 
[32P]-labeled transcripts produced by T7 RNA-polymerase (Promega) following 
linearization of the plasmid pGEM-3Zf(+)-chicken FerH-IRE with BamHI (New England 
Biolabs). 40 µg of protein and 1.3x106 dpm of labeled IRE-containing in vitro transcript 
were incubated for 20 minutes at room temperature. The total amount of IRP1 was 
assessed by in vitro reduction with 2% β-mercaptoethanol (2-ME)23 prior to the binding 
reaction. After treatment with RNAse T1, RNA-protein complexes were resolved on 6% 
non-denaturing polyacrylamide gels at 4°C. Bands corresponding to IRE/IRP complexes 
were quantified by phospho-imaging (Molecular Dynamics). 
 
Western blot analysis 
Cell pellets were lysed in sample buffer as described24 and 10-20 µg of protein separated 
on SDS-polyacrylamide gels. Protein transfer and loading were visualized by staining 
with acidic Ponceau-S solution. Thereafter, membranes were blocked one hour at room 
temperature with 1% low-fat dry milk in TBS and probed overnight with anti-horse spleen 
ferritin (Sigma-Aldrich), anti-mouse TfR1 (AbD Serotec) and anti-mouse eIF4E (Cell 
Signaling). After washing, filters were incubated with second antibody (IRDye700DX or 
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IRDye800DX conjugated IgG [H&L]; Rockland). After washing, immuno-reactive signals 
were detected with an Odyssey infrared imaging system (Li-cor Biosciences). 
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5.3.4. Results 
 
The binding activity of IRPs is modulated by oxygen in terminal differentiating but 
not in self renewing erythroblasts 
The main regulator of the binding activity of IRPs is iron. Nevertheless, other factors 
including oxygen are known to influence the regulation of iron metabolism via these 
proteins5,6. In order to investigate the role of oxygen in the regulation of iron metabolism 
during the development of erythroblasts we performed electro mobility shift assays 
(EMSA) with the cytosolic extracts of immature, non-differentiating as well as terminally 
differentiating cells (Figure 1A). First, we cultivated fetal liver derived primary 
erythroblasts under non-differentiating conditions and compared cultivation at low 
oxygen concentration (3% oxygen) to cultivation at atmospheric oxygen concentration 
(20% oxygen). The binding activity of IRP1 and IRP2 was only slightly affected by the 
different oxygen concentrations. 3% oxygen faintly reduced IRP2 binding activity 
whereas IRP1 binding activity was not affected. In contrast to this, terminally 
differentiating erythroblasts that were cultivated in 3% oxygen showed a binding activity 
reduction of IRP1 and IRP2 compared to cells cultivated in 20% oxygen. 
Since a change of IRP binding activity affects the expression of several proteins 
that are linked to the iron metabolism of the cell, we also determined protein levels of 
TfR1 and ferritin by western blot analysis. As expected, the expression of both proteins 
stayed constant in non-differentiating cells (data not shown) but were considerably 
altered in terminally differentiating erythroblasts when the oxygen concentration was 
reduced (Figure 1B). Corresponding to the well known posttranslational effect on the 
expression of these two proteins, ferritin protein levels were increased whereas TfR1 
protein levels were decreased, although the effect on ferritin was stronger. 
Other groups have already shown that the IRP binding activity is modulated by 
oxygen7. In order to compare the effects observed with differentiating erythroblasts to 
other cell types, we incubated J774 macrophages and mouse embryonic fibroblasts 
(MEFs) at 3% and 20% oxygen and measured the IRP binding activity by performing 
EMSAs. Interestingly, these two cell types showed diverse regulation of IRP binding 
activity in response to changed oxygen concentrations (Figure 1C). J774-macrophages 
cultivated at 3% oxygen reduced their IRP1 binding activity drastically compared to 20% 
oxygen while IRP2 binding activity increased in these cells. In contrast to this, MEFs did 
not show any difference in the binding activity of IRPs under those oxygen conditions. 
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Therefore, the effect of oxygen on the regulation of IRP binding activity in vitro was 
dependent on the cell type and in the special case of erythroblasts on the developmental 
stage of the cells. 
 
Low oxygen levels inhibit spontaneous differentiation during the outgrowth of 
immature fetal liver erythroblasts 
The regulation of iron metabolism via the binding activity of IRPs is of special importance 
during terminal erythroid differentiation since erythroblasts depend on the uptake of high 
amounts of iron for the biosynthesis of heme. Down-regulation of IRP binding activity as 
observed in our in vitro culture of differentiating erythroblasts at 3% oxygen leads to 
down-regulation of TfR1. The iron uptake via this receptor is essential for heme 
synthesis during erythropoiesis and thus a decrease in its expression would interfere 
with the accumulation of hemoglobin. Furthermore, down-regulation of IRP also reduces 
the accessibility of iron within the cell by up-regulating ferritin. Available cellular iron is 
trapped within the nano-cages that are formed by this protein, leading to the same effect 
as down-regulation of TfR1. Altogether this would interfere with heme synthesis and 
hence with normal erythroid differentiation. Tissue oxygen levels are normally in the 
range of 3-5%, therefore the incubation of erythroblasts at this concentration in vitro is 
favorable compared to atmospheric 20-21% oxygen that are never reached in tissues. 
Nevertheless, the observed decrease of iron supply that is linked to the decrease of 
oxygen to "physiological levels" during a phase of high iron demand contradicts this 
assumption. Since we used a well defined erythroid in vitro system for our studies, we 
were able to take a closer look at this seemingly paradox situation in the context of 
changed oxygen supply.  
First, we measured the size distribution of outgrowing murine fetal liver 
erythroblasts cultivated at 3% or 20% oxygen (Figure 2A). The major part of E12.5 fetal 
livers consists of erythroblasts of different differentiation status ranging from immature 
self-renewing cells to mature enucleated red blood cells. Immature murine fetal liver 
erythroblasts have a mean diameter of 9 to 11 µm. During the process of differentiation 
the diameter shrinks to about 5 µm.  
During the first days of cultivation at 20% oxygen, the originally heterogeneous 
population was enriched in immature cells due to the signals provided by SCF, dex and 
epo. After 5 to 6 days in culture the cell population consisted mainly of immature 
erythroblasts (Figure 2A, left panel). Starting with day 7, spontaneous differentiation of 
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this population occurred and resulted in a mixed population of mature and immature 
erythroblasts, although the combination of factors was not changed. This was not the 
case when we cultivated fetal liver cells in the same medium but at 3% oxygen. Within 7 
to 8 days these cells developed to a homogenous population of immature erythroblasts. 
Interestingly, these cells did not show spontaneous differentiation until day 12 of 
cultivation. Benzidine stainings of erythroblasts at day 7 of cultivation confirmed the 
above described oxygen dependent differences in cell size distribution (Figure 2B). 
Furthermore, the frequency of cells with a more condensed nucleus and with a 
hemoglobin containing cytoplasm showing a tendency for spontaneous differentiation 
was higher when erythroblasts were cultivated at 20% compared to 3% oxygen. 
In order to test if these effects are reversible we switched the erythroblasts from 
20% oxygen to 3% oxygen at day 5 (Figure 2A, middle left panel). After 2 days of 
adaption to the low oxygen concentration these erythroblasts remained in an immature 
state whereas those erythroblasts kept under normoxic conditions showed increased 
spontaneous differentiation. When this switch took place in the opposite direction by 
keeping the erythroblasts first at 3% oxygen and then shifting to 20% oxygen at day 10, 
the cells immediately started to differentiate and after 48 hours the major part of the 
population consisted of small, mature erythroblasts (Figure 2A, right panel). 
 
Oxygen concentration modulates terminal erythroid differentiation 
As shown above the oxygen concentration had an obvious effect on the outgrowth of 
erythroid precursors. Consequently, we also wanted to investigate whether a change of 
oxygen concentration affects the induced terminal erythroid differentiation. We are able 
to induce terminal erythroid differentiation of cultured erythroblast by the withdrawal of 
SCF, the replacement of dex by its antagonist ZK and the increase of epo concentration 
from 2 U/ml to 10 U/ml. This leads to a synchronous terminal differentiation of all 
erythroblasts, including substantial synthesis of heme and enucleation. In view of the fact 
that the iron metabolism of these cells is disturbed under low oxygen conditions (Figure 
1A, right panel and Figure 1B), their general response regarding differentiation would 
help to clarify if this modification of iron regulation is a primary effect due to the lack of 
oxygen or a secondary effect of disturbed terminal erythroid differentiation. 
Fetal liver cells were cultivated at 3% and 20% oxygen during erythroid 
outgrowth. At day 7 the cells were transferred into medium containing differentiation 
factors while keeping the oxygen concentrations constant. Under both oxygen conditions 
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the erythroblasts reduced their size during differentiation (Figure 3A). Nevertheless, 
erythroblasts showed a delayed size reduction when kept at 3% compared to 20% 
oxygen. The delayed cell size decrease of erythroblasts cultivated at 3% oxygen was 
accompanied by reduced proliferation, which resulted in a decrease of the cumulative 
cell number by more than 50% 48 hours after the induction of differentiation (Figure 3B). 
Furthermore, hemoglobinization was reduced by 40% (Figure 3C). Benzidine stainings of 
these erythroblasts confirmed the differences regarding cell size distribution and 
hemoglobin accumulation (Figure 3D). 
Taken together, these data show that 3% oxygen supplied by the used incubators 
interfere with normal terminal erythroid differentiation in our in vitro culture system. 
 
p53 -/- erythroblast are more sensitive to low oxygen concentrations during 
terminal erythroid differentiation than wild type erythroblasts 
Immortalized normal erythroblast clones isolated from fetal livers of p53-/- mice are 
characterized by reduced spontaneous differentiation when kept at non-differentiating 
conditions but behave otherwise like wt fetal liver erythroblasts25. We used such a clone 
(I/11) to further analyze the effect of oxygen on the proliferation and the differentiation of 
erythroblasts, since these cells do not show spontaneous differentiation and the switch 
between immature self renewal and terminal differentiation is strictly dependent on the 
factors added. Reduced oxygen levels had similar effects on the differentiation of I/11 
erythroblasts compared to wild type fetal liver erythroblasts. The cell size decrease was 
normal at 20% oxygen: 72h after induction of differentiation a major part of the 
population reduced its diameter to 5 µm (Figure 4A, left panel). As expected, 3% oxygen 
interfered with cell size decrease but interestingly, the effect was even stronger 
compared to wild type erythroblasts (Figure 4A, right panel). The whole population of I/11 
cells reduced the cell size only slightly each day. After 72 hours the mean diameter was 
still above 7 µm and cells with a diameter of 5 µm were virtually absent. Cell proliferation 
was also affected (Figure 4B). While I/11 erythroblasts increased the cell count more 
than 6 fold within a time span of 72 hours when cultivated at 20% oxygen, 3% oxygen 
reduced the increase to 2.5 fold. Furthermore, proliferation stopped after 48 hours 
indicating that differentiation was not only delayed but completely blocked. In addition, 
the mean heme amount/cell volume was reduced to 30% when the oxygen levels were 
reduced to 3% oxygen during differentiation (Figure 4C). Taken together, I11 cells are a 
 106 
 
perfect tool to further evaluate the effect of oxygen concentration and of parameters 
linked to oxygen supply on erythroid differentiation. 
 
Cell density and diffusion distance modulate the oxygen microenvironment of 
differentiating erythroblasts 
The oxygen concentration in the direct environment of in vitro cultured cells is dependent 
on the oxygen concentration in the incubator. Nevertheless, it is often neglected that the 
cell density, the height of medium and the metabolic rate of the used cell type play an 
important role regarding the oxygen supply of the cell15. In order to investigate if the 
erythroblasts cultivated in our in vitro setting sense an oxygen environment that 
corresponds to the oxygen concentration of the incubator we challenged the system by 
manipulating factors that are known to influence oxygen availability. 
First, we modulated the oxygen consumption rate per culture plate by reducing 
the number of erythroblasts seeded in the same volume of medium on an unchanged 
area. Proliferation rates of cells that were cultivated under self-renewing conditions were 
markedly affected by cell density (Figure 5A). When I/11 erythroblasts were readjusted 
daily to a concentration of 1x10E6 cells/ml, the cells grown at 3% oxygen showed a 50% 
decreased proliferation rate compared to cells that were grown at 20% oxygen. When 
the cell concentration was reduced by a factor of 4, the difference of the oxygen 
concentration did not influence the proliferation rates any longer. Interestingly the 
proliferation rate of cells cultivated at 3% oxygen at low density was comparable to the 
proliferation rate of cells seeded at high density in a 20% oxygen incubator. This 
demonstrates that the effective oxygen concentration in the environment of the 
proliferating erythroblasts in our in vitro system can be reduced by a high cell 
concentration. 
When we looked at differentiating erythroblasts we could observe that the cell 
size decrease was perturbed by low oxygen levels (Figure 4A). This effect was still 
present when we reduced the cell concentration from 2x10E6 to 5x10E5 cells/ml (Figure 
5B, left panel). Surprisingly, further reduction to 1.25x10E5 cells/ml erased any 
difference between the cultivation at 3 or 20% oxygen and the cell size distributions of 
erythroblasts 72 hours after the start of differentiation were practically equal (Figure 5B, 
right panel). The efficiency of heme accumulation was also dependent on oxygen 
concentration when differentiation was initiated at 2x10E6 cells/ml but this dependency 
diminished when the concentration was reduced, reaching comparable levels at 5x10E5 
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cells/ml and below (Figure 5C). Interestingly, the heme synthesis rate generally 
increased when the cell concentration became lower, indicating that heme synthesis was 
limited at higher cell concentrations. Comparable results were obtained when we looked 
at the proliferation rate during differentiation (Figure 5D). The observed reduction in 
proliferation caused by lower oxygen supply of the incubator at higher cell densities 
diminished with lower cell densities and was absent at a concentration of 1.25x10E5 
cells/ml. Taken together, our results clearly show that the cell density modulates oxygen 
availability during the culture of erythroid cells leading to lower effective oxygen supply 
than the actual external oxygen concentration provided by the incubator. 
Another oxygen-supply relevant parameter that we changed was the diffusion 
distance of oxygen through the medium that covers the cells. It is possible to reduce the 
distance to virtually zero if gas permeable tissue culture dishes are used15. Furthermore, 
other possible limiting factors that could be dependent on cell density can be neglected 
since these cultivation factors remain constant. When we cultivated I/11 erythroblasts in 
gas permeable dishes, we observed an effect that was comparable to a reduction of cell 
density. The proliferation rate of self renewing (Figure 6A) and terminal differentiating 
cells (Figure 6D) was similar in normal tissue culture dishes at 20% oxygen and in gas 
permeable dishes at 3% oxygen in contrast to the reduced proliferation rate in 
conventional tissue culture dishes at 3% oxygen. Interestingly, the proliferation rate of 
immature erythroblasts in gas permeable dishes at 20% oxygen was higher than in 
conventional dishes at the same oxygen concentration (Figure 6A). The heme synthesis 
rate was also positively affected by the usage of gas permeable dishes at 3% oxygen 
(Figure 6C). The cell size decrease could be improved but was still not as fast as with 
20% oxygen (Figure 6B). However, erythroblasts that were cultivated in gas permeable 
dishes at 20% oxygen showed a comparable retardation in cell size decrease (data not 
shown). This indicates that this is an inherent effect of the gas permeable dishes and not 
due to a limited supply of oxygen. 
 
2-oxoglutarate–dependent dioxygenase inhibitor DMOG prevents immature 
erythroblast from spontaneous differentiation in vitro 
Since the cultivation of erythroblasts at low oxygen levels resulted in a reduction of 
spontaneous differentiation we wanted to further investigate the mechanisms behind this 
observation. HIFs are the regulators of the transcriptional response to hypoxia in 
metazoan organisms. In mammalians their activity is dependent on the hydroxylation of 
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three residues of their α-subunits (either HIF1α or HIF2α), which leads to the subunit’s 
deactivation and degradation26-28. As this process is oxygen dependent, HIFs are active 
in a hypoxic environment. A simple possibility to activate HIFs despite high oxygen 
concentrations is by adding the 2-oxyglutarate-dependent dioxygenase inhibitor DMOG 
to cultured cells27. DMOG replaces 2-oxoglutarate, which is an essential co-substrate for 
HIF hydroxylation and therefore prevents HIF inactivation, since DMOG cannot be used 
by the relevant hydroxylation enzymes (PHDs, FIH). We used DMOG in order to 
investigate the role of HIFs in the regulation of erythroid differentiation. 
The effects of DMOG on the outgrowth of fetal liver erythroblasts were not only 
comparable to the incubation at low oxygen levels but resulted in an even more 
pronounced effect. While the population of untreated control cells proliferated and 
differentiated simultaneously as shown above, DMOG treated cells proliferated but did 
not show any tendency to differentiate as demonstrated by cell size distribution (Figure 
7A). This period of exclusive proliferation could be extended to at least 2 weeks, when 
DMOG was added regularly to the medium. 
Using flow cytometry we further looked at the expression levels of the cell surface 
markers CD117/c-Kit and CD71/TfR1 that change during the process of erythropoiesis 
(Figure 7B). CD117, the receptor of the stem cell factor, is generally expressed on 
immature hematopoietic cells29. At day 7 of cultivation we could observe that the majority 
of erythroblasts that were grown in medium containing DMOG expressed CD117. In 
contrast to this, the greater part of cells without DMOG grown at 20% oxygen showed no 
CD117 expression, demonstrating that these cells are more mature than DMOG treated 
cells. CD71 is expressed on virtually every growing cell as iron import is essential for cell 
growth and proliferation. Regarding erythroblasts, its expression is strongly increased 
during terminal differentiation due to the high heme synthesis rate which is linked to high 
iron demands. As expected, erythroblasts cultivated with DMOG showed a lower 
expression of CD71 when compared to cells cultivated without DMOG, supporting the 
assumption that DMOG treated cells are more immature. Although CD71 expression is 
generally accepted as erythroid differentiation marker, its expression is also regulated by 
iron metabolism and consequently also linked to heme synthesis per se. Benzidine 
staining of day 7 erythroblasts showed that heme synthesis was strongly reduced by 
DMOG (Figure 7C, upper panels). Furthermore, the untreated population consisted of 
erythroblasts at different stages of maturation ranging from immature cells with large 
nuclei to small, mature, heme containing and even enucleated cells. In contrast to this, 
the DMOG treated population consisted mainly of a homogenous population of non-
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differentiated cells. Taken all these data together, i.e. cell size distribution, the 
expression rates of erythroid markers, cell morphology and heme synthesis, this 
demonstrates that the addition of DMOG to the cultivated erythroblasts kept these cells 
in a more immature state than control cells. 
In order to find out how an immature continuously DMOG treated population 
reacts to DMOG withdrawal we divided an 8 days old homogenous population of fetal 
liver derived erythroblasts cultivated with DMOG into a cell population with prolonged 
DMOG treatment and a population cultivated without DMOG. Cells that were 
supplemented with DMOG continued to proliferate without signs of spontaneous 
differentiation for at least 10 days (Figure 7D, middle panel). Interestingly, erythroblasts 
without DMOG showed an increase of the mean sell size of about 1 µm during the first 
24 hours of DMOG withdrawal (Figure 7D, left panel). Thereafter the cells continuously 
reduced their mean cell size to 5 µm within 10 days. The cell size decrease was 
accompanied by an increase in the total proliferation rate until day 7 after DMOG 
withdrawal (Figure 7E). When we discriminated between the accumulating cell numbers 
of larger, immature cells (>7.5 µm diameter) and smaller, mature cells (4-7.5 µm 
diameter), we could observe that the higher proliferation rate of erythroblasts without 
DMOG was mainly caused by an increase in the number of small mature cells. In 
contrast, the relative amount of larger self renewing cells decreased, which consequently 
led to an increased “aging” of the population and finally to a stop of proliferation due to 
progressive depletion of immature erythroblasts. The decrease of cell size was 
accompanied by an increase of heme levels confirming terminal erythroid differentiation 
(Figure 7F; left panel). Both observations were confirmed by cytospin stainings. A major 
part of erythroblasts cultivated without DMOG was stained by benzidine indicating 
accumulation of heme and these cells also showed a cell size decrease which was 
accompanied by condensation of the nucleus or even enucleation (Figure 7C; lower 
panels). Erythroblasts that were grown in medium containing DMOG did not show this 
shift to more mature cells and continued to proliferate. 
After about three weeks in culture DMOG treated cells showed a less defined cell 
size distribution with somewhat increased proportions of smaller cells. Interestingly, at 
the same time proliferation rates began to decrease. Furthermore, the heme levels 
remained low, indicating that the cells did not differentiate. In order to test if these 
erythroblasts are actually still able to undergo terminal differentiation, we again divided 
the DMOG treated population into two cultures with and without prolonged DMOG 
treatment at day 19. The effects of DMOG withdrawal were comparable to the effects at 
day 8, including cell size decrease (Figure 7D, right panel), increased proliferation and 
 110 
 
heme synthesis rates (Figure 7F, right panel). However, the kinetic of spontaneous 
differentiation was accelerated and proliferation stopped within 5 days (Figure 7E). This 
indicates that although terminal differentiation was blocked by DMOG, the erythroid 
population became more inclined to differentiate if this block was removed. 
 
DMOG interferes with induced terminal erythroid differentiation 
The addition of DMOG to erythroblasts kept under non-differentiating conditions resulted 
in the extension of their proliferation potential linked to an abrogation of spontaneous 
differentiation when compared to cells without DMOG. Thus, we wanted to know whether 
there is an effect of DMOG on erythroblast induced for terminal differentiation. 
For this purpose we cultivated fetal liver cells under self renewal conditions in the 
presence of DMOG until we established a homogenous population of immature 
erythroblasts. Subsequently we induced terminal erythroid differentiation by changing the 
supplemented factors and cultivated them further with or without the addition of DMOG. 
When we measured the cell size distribution it was obvious that differentiating 
cells that were cultivated in the presence of DMOG reduced their cell size to a lesser 
extent than control cells without DMOG (Figure 8A). This observation was supported by 
cytospins of erythroblasts 48 and 72 hours after induction of differentiation (Figure 8B). 
Untreated cells showed a normal reduction in cell size including condensation of the 
nucleus and enucleation. In contrast to this, DMOG treated cells showed only a minor 
reduction of cell size and enucleation could not be observed. Furthermore, even 72h 
after induction of terminal erythroid differentiation heme synthesis was not detectable by 
benzidine staining in contrast to control cells without DMOG. Photometric determination 
of heme levels indeed showed that heme synthesis of DMOG treated cells was only 
slightly above or even beyond detection limits throughout differentiation, whereas control 
cells showed a normal increase of heme levels over time (Figure 8D). Interestingly, 
DMOG also negatively affected proliferation rates, resulting in a reduction of cell number 
by 50% 72 hours after induction of differentiation (Figure 8C). Finally, we also analyzed 
the expression of CD71 and Ter119, two known markers of terminal erythroid 
differentiation, by flow cytometry. The expression of both was increased on differentiated 
control cells as well as on DMOG treated cells compared to immature erythroblasts 
(Figure 8E). However, the increase was weak in DMOG treated cells compared to 
control, supporting an inhibitory effect of DMOG on terminal erythroid differentiation.  
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5.3.5. Discussion  
 
The activation of epo transcription via stabilization of HIF-2α in the kidney links 
hypoxia/oxygen-supply to erythropoiesis. The direct contribution of the oxygen 
concentration to the development of red cells in the erythropoietic tissues itself is less 
well understood. Furthermore, the regulation of the cellular iron metabolism, which is 
vital during erythropoiesis in order to supply the heme synthesis machinery with sufficient 
amounts of iron, is also affected by oxygen. The aim of this work was to analyze the 
effects of cultivation-dependent parameters on oxygen supply and furthermore, the direct 
effect of the oxygen concentration on erythropoiesis, including the regulation of the 
cellular iron metabolism by the IRE/IRP system.  
We could show that a reduction of the external oxygen supply had no influence 
on the binding activities of IRPs as long as erythroblasts were kept in an immature state. 
Nevertheless, when we induced terminal differentiation, which is accompanied by a 
drastic increase in heme biosynthesis and a considerable reduction in cell size, the 
IRP/IRE system responded to low oxygen concentrations by reducing IRP binding 
activity. This would be in conflict with an increased iron demand during this period of 
erythropoiesis, since reduced IRP binding activity leads to reduced iron import via TfR1 
and increased sequestration of iron by ferritin30. Indeed, the incubation of erythroblasts at 
low oxygen concentrations resulted in reduced heme levels. Surprisingly, we also 
observed disturbed cell proliferation and cell size decrease during induced differentiation 
at 3% oxygen compared to atmospheric oxygen levels. Apparently, reduced oxygen 
levels interfered with the whole process of terminal differentiation of the cultivated 
erythroblasts suggesting that the reduction of IRP binding activity was a secondary 
effect, caused by the inhibition of heme synthesis and the resulting iron overload31. This 
is supported by the fact that we could not observe a change in IRP binding activity in 
more immature erythroblasts, i.e. before the induction of heme synthesis.  
The occurrence of an inhibitory effect of low oxygen levels on erythroid 
differentiation was very surprising, since physiological oxygen concentrations in 
mammalian tissues are normally in the range of 3 to 5% or even lower, depending on 
oxygen supply and metabolic activity11. It is generally assumed that in vivo-like tissue 
culture experiments should be performed at oxygen concentrations corresponding to the 
physiological levels, especially if oxygen dependent processes are analyzed. 
Nevertheless, several groups have shown that the effective oxygen concentration that is 
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perceived by in vitro cultured cells is not equivalent to the oxygen concentration of the 
incubator but is also dependent on other factors, like cell density, metabolic rate or 
diffusion distance15. We could show that the cell density modulates the oxygen 
availability in our in vitro system and our results suggest that the effective oxygen 
concentration perceived by erythroblasts cultivated at atmospheric oxygen levels is in 
fact below 20%. Furthermore, when we used gas permeable dishes that eliminate the 
limiting effects of oxygen diffusion through the medium, we detected no difference 
between erythroblasts cultured at 3% oxygen and conventional cultivation at 20% 
oxygen, indicating that the oxygen supply of the cells is comparable. This implies that 
under conventional culture conditions combined with normal atmospheric oxygen supply 
the effective oxygen concentration is similar to physiological conditions during terminal 
erythroid differentiation. Consequently, when the oxygen concentration is decreased to 
3% the effective oxygen supply is further decreased and reaches hypoxic levels that 
interfere with the late stages of differentiation. This was still the case when the oxygen 
concentration was adjusted to less "hypoxic" levels of 6% oxygen (data not shown). 
Since HIFs are the transcription factors that regulate the cellular response to 
reduced oxygen supply, we wanted to analyze if they are also responsible for the 
observed effects on erythropoiesis. To test the role of HIFs, we added the HIF stabilizer 
DMOG to cultured erythroblasts. Surprisingly, the outcome was even more pronounced 
than with cells cultured under low oxygen levels. This observation can be explained by 
our method of cultivation, which includes the daily addition of fresh medium containing 
the respective factors. Hence, it was necessary to interrupt the cultivation in the low 
oxygen incubator and to expose the erythroblasts to atmospheric oxygen levels every 24 
hours. Therefore, the activity and stabilization of HIF-α is interrupted as well and has to 
be reestablished after the medium change leading to a gap in the activation of its targets. 
In contrast to this, DMOG is present continuously and activates HIFs without interruption, 
independent of exposure to oxygen and medium changes. 
As already described, the used erythroid in vitro model includes two phases of 
cultivation17. In the first phase, immature erythroblasts are cultivated in the presence of 
factors promoting self renewing with only a minor tendency for spontaneous 
differentiation. In the second phase, they are replaced by factors inducing synchronous 
terminal differentiation, which finally leads to a population of small, enucleated and highly 
hemoglobinized cells. In both phases, reduced oxygen supply as well as DMOG 
treatment inhibited cell size decrease, enucleation and heme synthesis, which resulted in 
a homogenous immature population in the first phase and perturbed terminal 
differentiation in the second phase of the cultivation. Obviously, low oxygen supply and 
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stabilization of HIF-α support self renewal of immature erythroblasts and interfere with 
terminal erythroid differentiation. 
Furthermore, the addition of DMOG to fetal liver cells not only prevented the 
terminal differentiation of erythroblasts, which resulted in a homogenous population of 
immature cells during the first phase of cultivation, but also prolonged their limited 
capacity to proliferate. The cell size distribution of the cultured cells already indicates that 
cells without DMOG become more mature within several days and the proportion of 
immature cells with still higher proliferation capacity decreased. Recently it has been 
shown that the expansion rate of purified BFU-Es but not of more mature CFU-Es can be 
increased by the addition of DMOG and it was demonstrated that HIFs and 
glucocorticoids, which are essential for stress erythropoiesis, share transcription 
targets16. Addition of DMOG to fetal liver cells would therefore result in an accumulation 
of BFU-Es in our culture system. This is in line with the observation that 24 hours after 
DMOG withdrawal erythroblasts increase their mean cell volume, which would confer 
with the transition of smaller BFU-Es to larger CFU-Es32. The BFU-Es isolated from fetal 
livers normally are able to proliferate for 10 days, which corresponds to the proliferative 
capacity of this cell type33,34. Nevertheless, our total fetal liver culture could be kept 
proliferating for at least 28 days, indicating that beside BFU-Es more immature cells with 
still higher proliferation capacity can be found in the cultivated population. These early 
erythroid progenitors would therefore be responsive to hypoxia and HIFs as well. 
Another explanation would be that the self-renewing capacity of BFU-Es themselves is 
prolonged under the influence of hypoxia.  
Although terminal erythroid differentiation was virtually absent throughout the 
incubation with DMOG, SCF and dex, the erythroblasts obviously became more 
disposed to differentiation during cultivation. While the population of fetal liver cells 
depleted of DMOG at day 8 of cultivation, needed about 10 days until all cells were fully 
differentiated, erythroblasts that were already three weeks in culture fully differentiated 
within 5 days as soon as DMOG was withdrawn. Additional characterization of cultivated 
erythroblasts treated with DMOG will help to clarify in detail how oxygen and HIF 
influence the different stages of erythropoiesis. 
Based on these data we can conclude that the oxygen concentration in 
combination with growth factors effectively and directly regulates the progression of 
erythroid differentiation and that the activity of HIFs is responsible for this oxygen 
dependent regulation. This is in perfect agreement with the in vivo situation, since the 
oxygen concentration in hematopoietic tissues increases in line with increasing maturity 
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of the developing erythroblasts12. Therefore, cultivation of maturing erythroblasts requires 
adjustment of the oxygen concentration during the process of terminal differentiation in 
order to assure in vivo like conditions. 
Since low oxygen concentrations inhibited the last phase of erythroid 
differentiation, we are confronted with a seemingly paradox situation. Hypoxia generally 
leads to an increased formation of fully developed erythrocytes mainly induced by an 
increase of epo synthesis in the kidney9,10,35. A direct inhibitory effect of hypoxia on 
erythroid differentiation would therefore contradict the observed amplification of 
erythrocytes. Based on our data, we want to propose a model that clarifies this paradox 
and furthermore demonstrates how hypoxia contributes to the increased generation of 
erythrocytes directly in the hematopoietic tissue. We show that there is an oxygen 
threshold that is essential for the decision between self renewal and differentiation. This 
threshold divides the hematopoietic tissue into a hypoxic area, which promotes self 
renewal and contains immature cells, and a normoxic area that allows terminal erythroid 
differentiation. If an organism is confronted with reduced oxygen supply, this will lead to 
a shift of the threshold leading to an enlargement of the hypoxic area. Hence, developing 
erythroblasts reside in the hypoxic area for a longer time period and therefore are able to 
stay in a self renewal state and divide more often before the onset of terminal erythroid 
differentiation compared to an organism that is sufficiently supplied with oxygen. This 
leads to an increase in the proliferation rate and consequently to an increased number of 
mature erythrocytes, since terminal differentiation can still take place in the more 
oxygenated regions. Thus, in our model hypoxia induces erythropoiesis indirectly via the 
induction of epo and directly via the oxygen distribution at the site of erythropoiesis in 
order to guarantee increased generation of erythrocytes.  
The promoting activity of dioxygenase inhibitors like DMOG on the early stages of 
erythropoiesis shows promising potential for a therapy addressing certain non epo 
responsive types of anemia16. Nevertheless, a possible therapy by the administration of 
these inhibitors must take into account that the site of early erythropoiesis is already 
hypoxic12. An additional activation of HIFs would indeed increase the proliferation rate of 
BFU-Es and more immature erythroid progenitors, but at the same time terminal 
erythroid differentiation would be perturbed. In vivo experiments including determination 
of oxygen concentration and expression of HIFs would therefore help to evaluate a 
possible therapy. 
Taken together, we could show that cultivation parameters like cell density and 
diffusion distance have to be considered, when oxygen is an important factor of in vitro 
Results 
115 
 
experiments. Furthermore, the oxygen concentration can be used as a regulator of 
erythroid development in vitro and is an important factor in the cultivation of 
erythroblasts. Finally we present a model, describing how hypoxia can contribute in vivo 
to induce erythropoiesis directly, additional to the activation of epo expression in the 
kidney.  
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5.3.6. Figures 
Figure 1 
 
Figure 1. The response of the iron regulatory system to changed oxygen levels is 
cell type specific. (A) Cytosolic extracts of in vitro cultured immature and differentiating 
erythroblasts (48 hours after induction of differentiation) were used for EMSA to analyze 
the binding activity of IRP1 and IRP2 at different oxygen conditions (3% and 20%). 2-
mercaptoethanol treated lysates were used as loading control. (B) The protein levels of 
TfR1 and Fer of the cell lysates described above were determined by western blot 
analysis. eIF4E was used as loading control. (C) Cytosolic extracts of J774 
macrophages and MEFs cultivated at hypoxic and normoxic conditions were analyzed 
for IRP binding activity.  
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Figure 2 
 
Figure 2. Low oxygen prevents spontaneous terminal differentiation of immature 
erythroblasts. Murine fetal liver cells were cultivated in medium containing SCF, dex 
and epo at 3% and 20% oxygen. (A) Cell size distribution was monitored daily with an 
electronic cell analyzer starting 4 days after the onset of cultivation. At day 5, a fraction 
of the erythroblasts cultivated at 20% oxygen was transferred to 3% oxygen and at day 
10 erythroblasts cultivated at 3% oxygen were transferred to 20% oxygen. Immature 
erythroblasts have a mean diameter of 9 to 11µm whereas mature differentiated 
erythroblasts show a diameter of 5µm. (B)  Seven days after starting the cultivation of 
fetal liver cells, cultured erythroblasts were cytocentrifuged onto glass slides and stained 
with benzidine and histological dyes. Decrease of cell size is accompanied by 
condensation of the nucleus and enucleation. Benzidine stain of hemoglobin containing 
cells results in a brown colored cytosol.  
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Figure 3 
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Figure 3. Hypoxia perturbs normal induced terminal differentiation of 
erythroblasts. Immature erythroblasts were cultivated under self renewal conditions for 
seven days at 20% and 3% oxygen and consequently switched to medium containing 
differentiation factors. (A) Cell size distribution was determined starting with the onset of 
differentiation. (B) Cumulative cell numbers of differentiating erythroblasts were 
calculated as described in material and methods; error bars indicate SD of mean, n=4. 
(C) Heme/cell volume of erythroblasts 48 hours after induction of differentiation was 
determined as described in material and methods; error bars indicate SD of mean, n=3. 
(D) Benzidine staining of terminally differentiating erythroblasts 48 hours after induction. 
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Figure 4 
 
 
Figure 4. p53 -/- erythroblast are more sensitive to low oxygen concentrations 
during terminal erythroid differentiation than wild type erythroblasts. p53 -/- fetal 
liver derived erythroblasts were induced to terminal differentiation. (A)Cell size 
distribution of these cells was measured every 24 hours starting with induction of 
terminal differentiation. (B) Cumulative cell numbers and (C) heme levels of 
differentiating p53 -/- erythroblasts; error bars indicate SD of mean, n=3. 
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Figure 5 
 
 
Figure 5. Cell density modulates the oxygen microenvironment of cultivated p53-/- 
erythroblasts. We cultivated p53 -/- fetal liver derived erythroblasts at different cell and 
oxygen concentrations and monitored the outcome on proliferation and differentiation. 
(A) Growth rate/day of self renewing erythroblasts cultivated at 3% and 20% oxygen at 
the indicated cell density; error bars indicate SD of mean, n = 3 (B) Differentiating 
erythroblasts were cultivated at the indicated cell densities and cell size distribution, (C) 
heme levels and (D) growth rates were determined 72 hours after induction of 
differentiation; error bars indicate SD of mean, n=3. 
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Figure 6 
 
 
Figure 6. The diffusion distance limits the oxygen availability for cultured 
erythroblasts. p53 -/- fetal liver derived erythroblasts were cultivated in conventional 
and gas permeable tissue culture plates (Lumox). (A) Self renewing erythroblasts were 
cultivated at 3% and 20% oxygen and the daily proliferation rate was determined; error 
bars indicate SD of mean, n = 5. (B) Differentiating erythroblasts were cultivated as 
indicated and cell size distribution and (C) heme levels were determined 96 hours after 
induction of differentiation. (D) Cell numbers were determined every 24 hours; error bars 
indicate SD of mean, n=3. 
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Figure 7 
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Figure 7. 2-oxoglutarate–dependent dioxygenase inhibitor DMOG reduces 
spontaneous differentiation and extends the proliferation capacity of immature 
erythroblasts. Fetal liver cells were cultivated at 20% oxygen in the presence or 
absence of DMOG. (A) Cell size distribution was monitored daily with an electronic cell 
analyzer, starting 3 days after the onset of cultivation. (B) Flow cytometry histograms of 
fetal liver cells cultivated for 7 days, stained for CD117/c-kit and CD71/TfR1. (C) 
Benzidine staining of erythroblasts cultivated for 6 days (upper panel) with or without 
DMOG. The erythroblasts initially cultivated with DMOG were further cultured in the 
presence or absence of DMOG until day 14 (lower panel).  
(D) A homologous, DMOG treated population of fetal liver cells was divided into two 
separate populations at day 8 of cultivation. One population was further supplemented 
with DMOG while the other population was cultivated without DMOG. This procedure 
was repeated at day 19. We determined cell size distribution, (E) cumulative cell 
numbers and (F) heme levels of these cell populations. 
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Figure 8 
 
 
Figure 8. DMOG interferes with induced terminal erythroid differentiation. Immature 
erythroblasts were cultivated under self renewal conditions and consequently switched to 
medium containing differentiation factors including or excluding DMOG. (A) Cell size 
distribution was determined daily, starting with the onset of differentiation. (B) Benzidine 
staining of terminally differentiating erythroblasts 48 and 72 hours after induction of 
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differentiation. (C) Cumulative cell numbers and (D) heme levels of differentiating 
erythroblasts. (E) Flow cytometry histograms of erythroblasts differentiating for 48 hours, 
stained for CD71/TfR1 and Ter119. Immature erythroblasts were used as control. 
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6. Discussion 
6.1. The regulation of iron metabolism in differentiating 
erythroblasts 
The proper acquisition of iron for heme synthesis is essential for the successful 
differentiation of erythroblasts, since reduced iron supply results in the development of 
anemia. Nevertheless, it is not sufficient that an adequate amount of iron-bound 
transferrin provided by the systemic iron household is available for heme synthesis. In 
fact, the differentiating erythroblasts must be able to handle the large amounts of iron 
that need to be imported, transferred to the mitochondria and finally incorporated into 
protoporphyrin IX in order to produce heme for the formation of hemoglobin. We are 
interested in how the cellular IRE/IRP system regulates the expression of ferritin, ALAS2 
and TfR1, three main components of the erythroid iron metabolism, in order to ensure an 
unobstructed heme synthesis. Theoretically, induced heme synthesis requires increased 
iron import via TfR1 and minimal iron sequestration by ferritin. Furthermore, ALAS2 
expression must be elevated in order to allow the synthesis of sufficient amounts of 
protoporphyrin IX. This is in perfect agreement with our observations when we examined 
the expression rates of these proteins in differentiating erythroblasts. Nevertheless, this 
contradicts the expected regulation pattern of the IRE/IRP system: Increased iron 
accumulation within a cell normally decreases the iron binding activity of IRPs, which 
consequently leads to the downregulation of TfR1 and the upregulation of ferritin47,59. 
Surprisingly, this expression pattern was not only turned upside down after the induction 
of terminal differentiation but also did not respond to the modulation of the iron 
household by the addition of the iron chelator desferrioxamine. In contrast to the 
observed discrepancies between expected regulation by the IRE/IRP system and 
observed expression of TfR1 and ferritin, ALAS2 translation was not only induced during 
differentiation but also still responded to the addition of desferrioxamine. Nevertheless, 
this comprises another inconsistency since due to the IREs in the 5' UTRs of both, 
ALAS2 and ferritin, their expression is expected to be regulated synchronously.  
 Thus, what are the mechanisms that explain the discrepancy in the expression 
between erythroblasts before and after the onset of differentiation? In fact, the increased 
import of iron is combined with increased iron processing during the production of heme. 
Although the exact path of iron from the endosomes to the mitochondria is still not 
known, it is obvious that iron is shuttled very fast to the site of heme synthesis. 
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Consequently, we hypothesize that the residence time of iron within the cytosol is 
reduced to a minimum leading to a virtually iron depleted environment. This results in an 
increase of IRP binding activity and explains the observed increase of TfR1 expression 
as well as the decreased translation of ferritin mRNA. Furthermore, the insensitivity to 
desferrioxamine treatment is explained by the fact that the cytosol is already iron 
depleted and hence the addition of the chelator is without effect. We challenged this 
hypothesis by artificially increasing the cytosolic iron concentration of cultured 
erythroblasts using FAC as additional iron source. Indeed, ferritin expression correlated 
with the used iron concentration indicating the full functionality of the IRE/IRP system. 
Moreover, inhibition of heme synthesis by the addition of INH or SA activated ferritin 
expression as well. This demonstrates that under normal conditions mitochondria use 
iron instantaneously for heme synthesis and as a result they deprive the cytosol of iron. 
Nevertheless, this still does not explain the differences between Fer and ALAS2 
expression. We hypothesize that two reasons are responsible for this discrepancy. First, 
although all IREs share common properties, it has been shown that due to differences in 
structure and sequence their binding affinity for IRPs varies147,148. Second, the presence 
of two IRPs that bind to specific IREs with different affinities allows a certain degree of 
fine-tuning of the regulatory system. Furthermore, the IRP1 binding activity is dependent 
on the iron sulfur cluster synthesis and becomes activated if the mitochondrial iron 
supply is reduced. In contrast to this, IRP2 stability is dependent on the presence of 
cytosolic iron. Therefore, IRP1 activity is linked to mitochondrial iron supply while IRP2 
mediates adaption to cytosolic iron availability respectively iron excess. In combination, 
these features allow a more specific regulation of IRE containing mRNAs and might 
explain the observed differences between ferritin and ALAS2 expression.  
 The generation of IRP1 and IRP2 deficient mice demonstrated that despite a 
basic redundancy of IRP activity, allowing survival without either one of the two IRP 
homologues, there are obvious differences in their phenotypes166. In general, IRP1 
deficiency is linked to only minor changes of iron distribution, whereas IRP2 knock out 
mice show several pathological effects including an erythroid phenotype. The observed 
microcytic anemia of IRP2 deficient mice correlates with reduced TfR1 expression in 
bone marrow cells and therefore it was proposed to be caused by reduced iron import of 
differentiating erythroblasts167,168. We further addressed this question by using IRP1-/- 
and IRP2-/- fetal liver cells. In line with the anemic phenotype of IRP2 deficient mice, 
differentiated IRP2-/- erythroblasts showed reduced heme levels compared to control 
cells demonstrating that anemia is indeed an intrinsic erythroid effect. Interestingly, TfR1 
expression of IRP2 deficient erythroblasts was reduced before the onset of heme 
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synthesis compared to control cells but the expression returned to normal levels during 
terminal differentiation, indicating that IRP independent mechanisms may contribute to 
TfR1 upregulation. In contrast, ferritin expression was elevated in IRP2-/- erythroblasts 
throughout the cultivation before and after the onset of heme synthesis. Based on these 
data we conclude that the upregulation of ferritin leads to the sequestration of iron in 
IRP2-/- erythroblasts and therefore is the main cause for the observed microcytic anemia 
in IRP2 deficient mice. Since TfR1 is expressed at high levels during the period of heme 
synthesis its contribution to the phenotype is of minor importance.  
Taken together, cultivated primary erythroblasts derived from IRP deficient mice 
are a perfect tool to investigate special aspects of iron metabolism during erythroid 
differentiation. For instance, further analysis will reveal the contribution of IRP1 and IRP2 
to the regulation of ALAS2 activity and thereby will clarify the discrepancy between 
ferritin and ALAS2 regulation mentioned above. 
 
6.2. The impact of oxygen on the regulation of erythropoiesis 
Oxygen has been shown to influence the binding activity of IRPs155,272,273. Furthermore, 
the oxygen concentration has an impact on differentiation in general and on 
erythropoiesis in particular, although the underlying mechanisms are not well 
understood261,266. Since we use a cell culture system in order to analyze the iron 
metabolism during erythropoiesis these oxygen dependencies are of special importance 
for our work. As a consequence, the application of conventional incubators supplied with 
atmospheric oxygen levels imply that the oxygen concentration is unphysiological 
compared to the in vivo situation. The reduction of the oxygen concentration to 
“physiological levels” (3-5% oxygen) indeed affected the IRP binding activity in terminally 
differentiating erythroblasts but surprisingly did not alter the binding activity in immature 
erythroblasts before the onset of heme synthesis. Furthermore, cultured fibroblasts 
showed no response to changes in oxygen supply, while macrophages responded, 
although the changes were distinct from those observed with differentiating 
erythroblasts. Consequently, we conclude that the effect of the oxygen concentration on 
the IRP binding activity is dependent on additional indirect factors. In the case of 
differentiating erythroblasts we could show that reduced oxygen in general had an 
inhibiting effect on terminal differentiation. In combination with SCF and glucocorticoids 
this resulted in the establishment of a homogenous population of immature erythroblasts 
with a minor tendency to spontaneously differentiate than cells cultivated at atmospheric 
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oxygen levels. On the other hand, the induction of terminal differentiation by the 
withdrawal of SCF and dex and the increase of epo concentration was inhibited by 
reduced oxygen levels which resulted in reduced proliferation, perturbed cell size 
decrease and reduced heme synthesis. As mentioned above, inhibition of heme 
synthesis during terminal erythroid differentiation increases cytosolic iron levels and 
leads to the downregulation of IRP binding activity. Taken together, this explains why the 
limited oxygen supply decreases the binding activity of both IRPs and why the IRPs of 
immature cells are not responsive to reduced oxygen since the differentiation-linked 
heme synthesis is not yet induced in these cells.  
 The average oxygen concentration in tissues is normally in the range from 3% to 
5%, but locally it is even lower183. Compared to these values the atmospheric oxygen 
concentration of 20-21% seems far too high. As a consequence some cell culture 
experiments are performed at oxygen concentrations that correspond to the in vivo levels 
in order to allow physiological conditions, especially if oxygen dependent processes are 
analyzed. Nevertheless several papers that addressed the question of oxygen supply in 
conventional tissue culture could show that the effective oxygen concentration is not 
equivalent to the ambient oxygen concentration267,269,271. Moreover, the limitations of 
oxygen diffusion in combination with high oxygen consumption rates can lead to a 
virtually anoxic environment for certain cell types268,271. We modulated the cell density 
and reduced the diffusion distance in our cell culture system in order to find out whether 
the cultivated erythroblasts face oxygen concentrations that are below the levels 
provided by the used incubators. As mentioned above, the reduction of the ambient 
oxygen concentration to 3% resulted in the inhibition of erythroid differentiation under 
conventional culture conditions. The reduction of the cell density that at the same time 
reduces the overall oxygen consumption led to a complete elimination of this effect. 
Similar results were achieved by reducing the diffusion distance using gas permeable 
dishes. Hence, our data clearly show that the conventional culture conditions result in a 
decrease of the effective oxygen concentration in the direct environment of the 
erythroblasts compared to the ambient levels. Furthermore, we can assume that under 
modulated culture conditions the diffusion to consumption ratio increases and 
consequently the effective oxygen concentration approximates the levels supplied by the 
incubator. This illustrates that an effective oxygen concentration of 3% still allows normal 
erythroid differentiation and only lower levels interfere with the maturation of these cells.  
The link between erythropoiesis and oxygen levels corresponds to the in vivo 
situation in hematopoietic tissues, where the increase of maturity correlates with an 
increase of oxygen concentration266,274. Our data show that oxygen is able to actively 
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regulate the ongoing of erythropoiesis, which allows its fine tuning during a hypoxic 
situation. A systemic oxygen undersupply not only induces epo production in the kidney, 
but also increases the low-oxygen area in the hematopoietic tissues. Consequently, this 
leads to a prolonged proliferation period of erythroblasts before the onset of terminal 
differentiation and, in combination with increased epo levels, eventually results in an 
increased number of mature erythrocytes.  
Since our data show that the oxygen concentration directly regulates the 
development of erythroblasts we were interested in the mechanisms that are responsible 
for this effect. Promising candidates that might be involved in the regulation of 
erythropoiesis are the HIF proteins, which are responsible for the main part of the 
transcriptional response to reduced oxygen supply. 2-oxoglutarate dependent 
oxygenases induce the inactivation and degradation of the HIF-α subunits if oxygen is 
present, but these enzymes can be inhibited by the addition of 2-oxoglutarate analogs 
like DMOG207. The addition of DMOG to cultured erythroblasts indeed resulted in the 
same effects that we observed at reduced oxygen concentrations, including reduced 
heme synthesis, cell size decrease and proliferation. Moreover, the proliferation capacity 
of immature erythroblasts could be extended even longer than with low oxygen supply. 
Therefore, our data demonstrate that the inhibition of 2-oxoglutarate dependent 
oxygenases is sufficient to reproduce hypoxic conditions. Recently, Flygare and 
coworkers presented comparable results that show a positive effect of DMOG on the 
proliferation of cultivated BFU-Es, although they report increased proliferation in contrast 
to prolonged proliferation as presented in our work and they do not describe an inhibiting 
effect of DMOG on terminal erythroid differentiation275. They could show that 
glucocorticoids and HIF share common target genes and therefore propose that this 
redundancy is responsible for the effect on erythroid proliferation. Nevertheless, it cannot 
be excluded at the moment that oxygenases not involved in the regulation of HIF-α may 
contribute as well. Currently we are generating erythroid cells that express a stable and 
active version of HIF-1α in order to clarify these uncertainties.  
Taken together we could show that the oxygen concentration directly affects 
erythropoiesis. Furthermore we present a model that incorporates these observations in 
the systemic response to hypoxia. Finally, we demonstrated that the underlying 
mechanism is dependent on the activity of 2-oxoglurarate dependent oxygenases. 
Further analysis of the involved HIF-regulated genes will contribute to a better 
understanding of the direct contribution of oxygen concentration to the regulation of 
erythropoiesis. 
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